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Abstract 
Toxic metals such as cadmium (Cd2+) have been shown to bind to and interfere with 
various calcium (Ca2+) binding proteins including the regulatory protein cardiac troponin C 
(cTnC).  Recent structural data has shown that Cd2+ binds to both EF hand Ca2+ binding loops in 
the regulatory N-domain of human cTnC including EF hand loop I, which normally does not 
bind metal. Although the data reveal two Cd2+ ions bound to the protein, the binding constants 
and other thermodynamic parameters are not known.  Therefore, the goal of this research project 
is to use Isothermal Titration Calorimetry (ITC) to obtain thermodynamic parameters such as K, 
ΔH, ΔG and ΔS of Cd2+ binding to both the full length and N-domain (amino acid residues 1-89) 
of HcTnC and compare the parameters to our previous data with Ca2+. Through our results we 
hope to shed light on potential mechanisms of cadmium toxicity. 
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 Chapter 1: Introduction 
 
1.1 Chemical Properties of Cadmium 
 Cadmium is a member of the Group 12 transition elements of the Periodic Table (Z = 48, 
atomic mass 112.41 g/mol) and therefore contains a stable d10 electron configuration 
([Kr]4d105s2).  It can exist in the +1 (Cd+) oxidation state but the closed d-shell stabilization 
causes cadmium to almost exclusively be found in the +2 (Cd2+) oxidation state in the natural 
environment [1]. Cadmium is found in the earth’s crust with a concentration in the lithosphere of 
0.08–0.1 ppm, which is roughly 650 fold lower than its Group 12 neighbor, Zinc [2,3], and is 
characterized  by its relatively low melting (321 °C) and boiling (767 °C) points and a density 
equal to 8.65 g/cm3 at 20 °C [1,4].  
Cadmium is most abundantly found as CdS in the crystal lattice of various ores, mainly 
those involving Zinc [3]. This common occurrence is due to the Hard Soft Acid Base (HSAB) 
properties of cadmium. The HSAB theory defines hard acid and hard base ions as those that 
possess small atomic/ionic radii, high oxidation states, and low polarizability, while exclusively 
hard bases possess a high electronegativity [5]. Soft acids and soft bases, on the other hand, tend 
to have large atomic/ionic radii, low or zero oxidation states, and high polarizability, while low 
electronegativity is an additional trait of soft bases. Furthermore, soft acids tend to form stable 
covalent bonds with soft bases while hard acid ions tend to form ionic bonds with hard base 
anions. As a soft Lewis acid, the Cd2+ ion prefers to interact with soft ligand bases, such as 
sulfur, resulting in a very stable structure. The stable interaction between cadmium and sulfur 
make zinc ores such as sphalerite, (Zn/Fe)S, a prime source for cadmium [6,7]. 
 
 
 Cadmium-sulfide salts can be extracted as by-products from the refinement process of 
zinc ore bodies. Once isolated, these salts are collected and further used as additives in various 
commercial products. For example, cadmium sulfide, the most common salt, forms a stable 
crystal lattice that produces a yellow hue when subjected to light. Therefore, this salt is used as a 
yellow pigment and serves as a popular additive in various paints and coloring materials [7,8]. 
Cadmium sulfide can also serve as a p-type semiconductor by coupling with a doped 
semiconductor to produce photovoltaic cells for solar panels [9].   
 Cadmium can also be found in complex with other elements, such as selenium. CdSe 
salts is another example of a stable cadmium complex that has a wide variety of uses. Similar to 
cadmium sulfide, CdSe is often used as a color additive due to its red pigment, commonly known 
as cadmium red. To painters who work with pigment based paints, cadmium yellows, oranges, 
and reds are the most brilliant and long-lasting colors to use [10]. Cadmium’s versatile role 
makes it a very viable material for the production of pigments, color plastics, inks, paints, rubber, 
and other consumer goods. It also serves as a major source for metal plating, the production of 
NiCd batteries, and as a neutron absorber in nuclear reactors [11]. 
 
1.2 Cadmium Mobilization and Exposure  
 Cadmium is mobilized in the environment naturally through processes such as volcanic 
eruptions, physical and chemical weathering of parent rock material or derived soils, burning of 
vegetation, sea salt spray, and the production of marine biogenic aerosols [12-15]. Cd2+ is 
additionally mobilized through human activities, such as the processing of zinc ores, combustion 
of fossil fuels, manufacturing and usage of cadmium containing products, and incineration of the 
former waste. From the 1930’s to 1990, cadmium production rose from ~20 tons/ year and 
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stabilized at ~20,000 tons / year [16]. This increase is most likely attributed to cadmiums many 
uses in today’s consumer products such as NiCd batteries, pigments, and plastic stabilizers [17]. 
These anthropogenic sources account for the majority of cadmium emitted into the environment 
[16]. 
This increase in environmental exposure has led to accumulated levels of cadmium in air, 
water and food sources, thereby enabling numerous routes in which humans can be exposed to 
this metal. It is estimated that workers in certain occupations, such as the mining and farming 
industries, are exposed to cadmium at significantly higher levels than the general public [18]. 
Similarly, people living in areas contaminated with cadmium are exposed to higher amounts of 
the metal. Other sources of human exposure to cadmium include diet and cigarette smoke due to 
the high accumulation in various plants, particularly tobacco, and a variety of food sources.  
 The average person in the US consumes approximately 30 µg of cadmium per day 
through food sources [18]. However, this value may increase or decrease depending on the types 
of food an individual includes in their diet. For example, certain food categories are considered 
to have higher levels of cadmium, such as rice, soybeans, peanuts, bivalve mollusks, and oysters 
[19,20]. In Pacific oysters, cadmium levels are found to be 13.5 mg/kg dry weight while an even 
higher cadmium content was reported for some New Zealand Bluff oysters [21]. Oilseeds, such 
as sunflower seeds, peanuts, and flaxseeds, are shown to accumulate cadmium from the soil at 
levels ranging from 0.2 to 2.5 mg/kg. High cadmium levels (7-76 mg/kg wet weight) were also 
found in the offal of dugongs (marine mammals similar to manatees) and turtles [22].  
 Exposure to cigarette smoke is another major source of cadmium exposure. Tobacco 
plants selectively accumulate cadmium in the form of Cd2+ ions from the soil and typically 
contain 1-2 µg of cadmium/g dry weight [23]. This amounts to 0.5-1 μg of cadmium per 
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cigarette. 10% of inhaled cigarette smoke is deposited in the lungs while 30-40% of the inhaled 
smoke is absorbed into the systemic blood circulation [23]. Therefore, smokers are found to have 
4-5 times higher cadmium blood levels and 2-3 times more cadmium in their kidneys [23]. 
The main routes of cadmium absorption in the body are through the gastrointestinal tract and 
lungs. An average individual ingests between 30-50 µg/day [23] of cadmium thus absorbing 
between 1 and 10% [24]. The intestine normally absorbs 6% of total ingested cadmium [23,24]. 
However individuals with low iron or essential metal deficiency are reported to absorb an 
average of 9% ingested cadmium. In addition, the lungs, have been reported as the major route of 
cadmium adsorption with the average person absorbing 50% of inhaled cadmium through this 
route [25]. The skin is not a prominent route of absorption but it is also known to intake a small 
percentage (~0.5%) of cadmium upon exposure [23].  
 
1.3 Cadmium Toxicity 
Although cadmium may be useful in the production of various materials, it does not serve 
a biological role in maintaining the function and regulation of cellular life in the cellular tissues 
of higher ordered species. This metal is considered toxic, because when absorbed, Cd2+ can 
interact strongly through covalent bonds with the sulfur atoms of various protein ligands leading 
to unintentional inhibition or activation of biological pathways. For example when cadmium is 
absorbed by tissue cells, cadmium can act as a catalyst in forming reactive oxygen species, 
increase lipid peroxidation, and decrease circulating antioxidants, by interacting with glutathione 
and protein-bound sulfhydryl groups [26]. In humans, such interactions are known to interfere 
with the cellular function and regulation in the tissues of the kidney, liver, and heart. As a result, 
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chronic exposure and constant accumulation of cadmium at these sites has been contributed to 
the onset of severe health issues in these specific tissues [12,27]. 
Previous studies have demonstrated that certain health complications in the kidneys, 
liver, or heart, arise when cadmium accumulates to specific concentrations at these target tissue 
sites. For example, cardiovascular effects have been reported at cellular levels as low as 0.1µM 
Cd2+ concentration [28] while urinary Cd2+ levels greater than 0.88 µg/g creatinine are shown to 
increase the risk of myocardial infarction in women [29]. Additionally, glomerular impairment 
has been reported at urinary cadmium levels of 0.8 µg/g creatinine [30]. Furthermore, sustained 
blood and urine levels in a range of 25-50 μg/L or 25-75 μg/g creatinine, respectively, have been 
shown to induce renal failure in patients chronically exposed to cadmium metal. Reportable 
creatine levels higher than those previously discussed, has been associated with death, mostly as 
result of complete renal dysfunction [31]. Although these values may seem small, they are 
obtainable when considering the typical dietary intake of cadmium is about 30-50 micrograms of 
cadmium per day (µg/day) [18].  
Cadmium exposure is a concern to human health considering the toxic effects induced by 
the metal at such low concentrations. The effects of cadmium toxicity on cardiovascular disease 
(CVD) is of particular interest in the research field, considering CVD is the number one killer of 
American males and females [31].  In 2004 an estimated 17.1 million people died due to CVDs 
and this number will further increase to an estimated 23.6 million by 2030[31]. Hypertension, 
and hypercholesterolemia, constitute about 50–75% of all CVDs, while 25-50% of causes for 
CVD still remains unknown. Although there is still an urgent need to search for and define new 
CVD risk factors, recent studies have provided promising results in pursuit of identifying 
possible mechanisms of cadmium toxicity on CVD [31].  
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A recent crystal structure (Figure 1C), has demonstrated that cadmium can bind to the N-
terminal regulatory domain of cardiac Troponin C (cTnC) [32,33], a regulatory protein 
responsible for maintaining muscle contraction in the heart [34]. This protein contains two 
calcium binding EF hand motifs in the N-domain, defined as EF hand loop II, or the calcium 
binding loop, and EF hand loop I, which is a vestigial site and does not bind calcium, see Figure 
1B [34]. The study shows that when cTnC is subjected to cadmium, Cd2+ metal ions not only 
interact in both EF hand loops at the N-terminus of the protein, but the binding of this metal 
induces a slight structural transition in the protein that differs from that observed when calcium 
binds to the N-domain of cTnC [32].  Cadmium binding to either EF hand I or II may adversely 
alter the function of the protein. 
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 Figure 1. (A) The EF hand loops I and II in the N domain of cTnC. (B) Ca2+ binds to EF 
hand loop II but not EF hand loop I [35]. (C) Crystal structure demonstrates that in the 
presence of Cd2+ both EF hand sites bind Cd2+ metal [32,33].  
 
 
Although one can speculate that the presence of Cd2+ in cardiac cells can disrupt protein 
function and hence muscle regulation, by interacting with the regulatory N domain of cTnC, 
there is not enough information to deduce a mechanism for the effects of cadmium toxicity on 
CVD. Further experimental investigation is needed to determine if cadmium binding to cTnC 
effects the calcium affinity for the protein, and in turn, effects the function of cTnC. 
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1.3.1 Fate and Transport of Cadmium in the Cell 
 Cadmium is absorbed in the body and taken up in the liver as the Cd2+ ion where it forms 
complexes with small peptides and proteins via sulfhydryl groups, including glutathione (GSH) 
or the high affinity metal binding protein metallothionein (MT) [36]. Cd2+ has been shown to 
bind to metalloproteins with high affinity, evident by the apparent stability constants for MT and 
GSH of ~10–25–10–14 M–1 and ~10–9 M–1, respectively[37,38]. This high affinity binding enables 
the displacement of essential metals from these proteins by ligand exchange [39-41] which may 
result in inhibition of their function. However, once bound to the protein, Cd2+ complexes such 
as Cd2+-GSH or (Cd2+)7-MT are then either secreted into the bile or released into circulation [27] 
where they are rapidly transported by the blood to different organs in the body. These complexes 
can then exchange Cd2+ with cellular membrane bound transporter proteins or be taken up by 
cells via receptor-mediated endocytosis [42]. 
 Cd2+ uptake is most commonly known to occur through facilitated diffusion and active 
transport via membrane bound ion channels and solute carriers. However, since Cd2+ is 
considered non-essential in humans, cells lack specific entry sites for this toxic metal. Therefore, 
Cd2+ is able to move to the interior of the cell by binding to transport membrane proteins that are 
specific to essential metals. Cd2+ can also enter cells by following the massive fluxes of other 
cations, which can be triggered by changing conditions, especially for excitable cells, via 
channels with leaky selectivity filters [43]. 
Another proposed pathway for Cd2+ uptake in cells is through receptor-mediated 
endocytosis. This occurs when Cd2+ is in complex with low molecular weight thiols, such as 
glutathione (GSH) or cysteine (Cys), which serve as molecular homologs. These complexes can 
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enter cells through organic transporter sites by mimicking amino acids, oligopeptides, or organic 
cations [7]. 
Once inside the cell, Cd2+ can impose multiple effects on cellular functions including 
cell-cycle progression, DNA replication and repair, differentiation, and apoptotic pathways [44]. 
Specifically, (Cd2+)7-MT complexes, are analogous to endogenous biological molecules [41]. 
This “molecular mimicry” enables the transport of Cd2+ to cellular tissues if those target cells 
possess transport pathways for essential metals or biological molecules [41]. Therefore, organs 
which utilize essential metals for various functional purposes, such as the liver, kidney, testis, 
spleen, heart, lungs, thymus, salivary glands, epididymis, and prostate, serve as major cadmium 
storage sites [26,45]. 
After Cd2+ moves into cells, its estimated half-life in various tissues is 10 years or greater 
[46,47]. This long half-life is in part due to the affinity of the metal with intercellular transport 
biomolecules and metal binding proteins. Transport biomolecules located on the interior of a cell 
are known to have a stronger affinity for cadmium when compared with the affinity of this metal 
to exterior membrane proteins. Due to these strong interactions, Cd2+ is prevented from diffusing 
out of the cell, thereby accumulating in tissues overtime. Also, the ability of Cd2+ to interact with 
intracellular protein sites can greatly affect the overall processes involved in the cell. This 
imposes a great threat to the lifespan of certain cells and tissues, and ultimately, the overall 
health and quality of life for a specific individual.  
 
1.4 Cd2+ Interactions with Proteins 
According to “Hard Soft Acid Base Theory” (HSAB), Cd2+, a soft metal ion, prefers to 
interact with soft base ions such as sulfur. Previous research has focused on the covalent thiolate 
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bond formed between Cd2+ and the cysteine residues of a variety of proteins [48]. As mentioned 
above, much work has been done to elucidate Cd2+ to cysteine residues present within 
metallothioneins and other transporter proteins [36]. Metallothioneins have been reported to play 
a detoxification role and are upregulated under heavy metal stress [36]. 
Cadmium ions have been shown to coordinate to the metal binding sites of carbonic 
anhydrase and horse liver alcohol dehydrogenase through means of two cysteines and one 
histidine residue [49,50]. Although Cd2+ is the native cofactor of carbonic anhydrase of the 
marine algae Thalassiosira weissflogi [51], the interaction of this metal within mammalian metal 
binding proteins is non-essential and thus considered to be a toxic interaction [52]. More 
recently, Cd2+ has been shown to form a thiolate bond with the sulfur atom of the cysteine 
residue in the EF hand 1 site of Ca2+ binding protein, human cardiac TnC (HcTnC) [33]. 
In addition to cysteine residues, Cd2+ has been found to coordinate with a very high 
affinity to oxygen rich metal binding sites.  In particular, Cd2+ can bind to EF hand proteins that 
are specific for Ca2+ with a similar geometry and coordination number as Ca2+. Although Cd2+ 
and Ca2+ differ in their HSAB properties and oxygen is considered a hard base, both calcium and 
cadmium have similar ionic radii and size to charge ratios. The ionic radii for Ca2+ and Cd2+ are 
0.99 Å and 0.97 Å respectively [53] while the charge/size ratios reported for Ca2+ and Cd2+ were 
2.02 e/Å and 2.06 e/Å, respectively [53].  
Due to the similarities listed above, Cd2+ has often been used as an effective substitute 
and probe for many Ca2+ binding proteins [52,54]. An isotope of cadmium, 113Cd, is often used in 
the NMR analysis of calcium binding proteins [55,56,56-59].  Several crystal structures of EF 
hand proteins bound to Cd2+ have been reported: parvalbumin [60], calpain [61], sTnC [57], and 
cardiac troponin C (cTnC) [32]. The primary coordination spheres of Cd2+ in these proteins were 
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compared to their Ca2+ counterparts and all were shown to adopt the pentagonal bipyramidal 
geometry, except for EF I in cardiac troponin C [32].  Since Cd2+ can replace Ca2+ in proteins 
without disrupting the protein structure, many EF hand proteins have been shown to be activated 
by Cd2+ including CaM, Calbindin D9K, and skeletal troponin C (sTnC) [56,62,63].  
   
 
Figure 2. Interactions between Cd2+ and the calcium binding sites of parvalbumin [60], 
calpain [61], C-domain sTnC [57], and the EF I (functional, calcium site) and EF II (vestigial 
site) in the N terminal domain of cTnC [32]. Cd2+ coordinates in each of these sites, except 
for EF I, and EF II of cTNC in pentagonal bipyramidal geometry. A distorted pentagonal 
bipyramidal geometry and a distorted octahedral geometry is observed for the coordination of 
Cd2+ in sites EF II and EF I of N-cTnC, respectively. 
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1.5 EF Hand Proteins  
In order to understand how Cd2+ may activate or alter the function of EF hand proteins, it 
is important to first understand the role Ca2+ ions plays in the chemistry of these proteins. Ca2+ 
serves as an important intracellular signaling ion in biological systems and is used in a variety of 
intracellular signaling pathways such as fertilization, cell differentiation, muscle contraction, and 
apoptosis [54].  Intracellular “free” Ca2+ ion concentrations range from 10 to 100 nM while 
extracellular concentrations are found to be ~ 1.2 mM [64].  This gradient helps facilitate Ca2+ 
entry into cellular cytoplasmic space thus elevating intracellular calcium concentration to a range 
of 1 to 100 μM [64].  
Since Ca2+ is an important ion to biological systems with diverse functions, calcium 
concentrations are tightly regulated both intracellularly and extracellularly.  Once Ca2+ flows into 
the cytoplasm of a cell it becomes bound to a wide variety of calcium binding proteins (CaBP). 
Many of these CaBP’s belong to a homologous family that bind this metal cation using a 
characteristic helix-loop-helix structural motif, termed the EF hand [65]. These proteins can bind 
to the Ca2+ ion with association constants ranging from 105 M-1 to well above 1010 M-1 [64] 
The EF hand motif was first discovered in 1973 when Kretsinger and coworkers [66] 
showed calcium bound in a distinct E-helix-loop-F-helix structure of the crystallized protein 
parvalbumin. This discovery gave rise to the EF hand Ca2+ binding motif which has now been 
identified in over 3000 proteins, all of which share homologous structures. The EF-hand motif is 
among the most common in animal cells [67] and more than 1000 have been identified from their 
unique amino acid sequences. The turn–loop structure provides the bulk of the ligands for the 
bound cation [65].  
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These motifs are usually organized into structural units/domains containing two or more 
EF hands that form highly stable helical bundle [68]. Because of its specificity for Ca2+, this 
motif is a key component of various proteins in calcium signaling pathways and, not 
surprisingly, has been evolutionarily conserved.  
 
 
 
Figure 3. A representation of the E-helix-loop-F-helix structure that constitutes the EF 
hand motif. Calcium ion coordinate with the ligands available in the loop region of the EF 
hand structure [69].  
 
 
1.5.1 Classes of EF Hand Proteins 
 The EF hand is thought to have originally developed from a common precursor domain. 
It is believed that small variations between EF hand proteins are a result of successive gene 
duplication and deletion. These differences in sequences and structures allow EF-hand proteins 
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to perform a diverse range of functions. There are two primary classes of EF-hand proteins: Ca2+ 
buffer and Ca2+ sensors.  
The first category of EF hand proteins are known as Ca2+ signal modulators, or Ca2+ 
buffers. These proteins modulate the duration of Ca2+ signals and help maintain Ca homeostasis 
within a cell [70]. They do so by temporarily binding free Ca2+ ions in order to transmit the 
signal throughout the cell, or to remove the metal from the cell [65].  Since these proteins do not 
interact with target sites like sensors proteins, these calcium binding molecules are considered to 
interact with calcium for structural purposes. Because of this, EF hand buffers are usually found 
at higher concentrations in a cell and usually demonstrate higher affinities for calcium than 
sensor proteins. Also, the interaction between calcium and the EF hand sites of buffering proteins 
induces a significantly smaller conformational change in the protein when compared to the 
structural changes observed when calcium binds to sensor proteins [65]. Examples of buffer 
proteins are parvalbumin, calretinin, and calbindin [65]. 
 The second class of EF hand proteins include the Ca2+ sensors. These are proteins or 
molecules that bind Ca2+ as a result of an increase in concentration of calcium. Protein sensors 
respond to this signal by interacting with the metal ion, which in turn, induces a structural change 
throughout the protein, thereby exposing binding sites for target proteins to interact. This 
interaction causes a structural change in the protein, which further facilitates subsequent 
interactions with other molecular components in the cell. By means of this interactive cascade of 
events, diverse biochemical responses are induced, and the original signal is ultimately translated 
from cell to cell [65].  Examples of Ca2+ sensors are CaM, recoverin, myosin light chain proteins, 
s100 proteins, and TnC [66].  
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The binding of Ca2+ to sensor proteins is accompanied by conformational changes within 
the protein. For example, the inter-helical changes within the amino and carboxy-terminal EF 
hand domains of CAM [71-73] and the amino-terminal domains of skeletal muscle TnC  are 
shown to change 60° upon Ca2+ binding [66]. This conformational change is considered large 
when compared to the inter-helical movements of EF hand helices in Ca2+ buffering proteins 
such as calbindin D9K and recoverin [66]. The angles observed in EF hand domains of these 
buffering proteins are shown to deviate from each other at an angle of 12° or less [74]. 
Protein domains showing large conformational changes are known to have a trigger 
function in the activation of target proteins and therefore can be termed regulatory domains [66]. 
Also, as part of their regulatory role, these proteins are shown to contain EF hand sites that have 
a lower affinity for calcium when compared to that of buffering proteins. The selective nature of 
these proteins for metal ions is characteristic of their role as regulatory molecular units in 
biological pathways. 
 
Table 1: A description of the different classes of EF hand Ca2+ binding proteins, Ca2+ buffers 
and Ca2+ sensors, and their respective differences.  
EF hand 
Class Function 
Binding 
Affinity  
Induced 
conformational 
change 
Examples 
Ca2+ 
Buffers 
Interact with Ca2+ for 
structural purposes 
High affinity 
for Ca2+ Small 
Parvalbumin, 
Calretinin, and 
Calbindin 
Ca2+ 
Sensors 
Interact with calcium 
for regulatory 
purposes 
Low affinity 
for Ca2+ Large 
CaM, Recoverin, 
Myosin light chain 
proteins, s100 proteins, 
and TnC 
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1.5.2 Calcium Binding Loop of EF Hand 
   The EF hand loop is commonly referred to as positions 1-12 where amino acids located at 
positions 1, 3, 5, 7, 9, and 12 participate in chelating Ca2+ ion.  The chelating residues of the loop 
are defined based on their position during calcium coordination and sometimes arrange 
themselves in a linear position, while others take on a tertiary geometry, imposed by their 
alignment on the axes of a pentagonal bipyramid. The axial positions are defined as 1(+X), 
3(+Y), 5(+Z), 7(-Y), 9(-X), and 12(-Z); the Y and Z axis pairs align along the vertices of an 
approximately planar pentagon, and the x-axis pair takes up an axial position perpendicular to 
the Y/Z plane [65]. Figure 4 demonstrates the EF hand calcium binding loop (functional loop) 
and the amino acids involved in the coordination of the calcium ion.  
 
 
Figure 4. A representation of Ca2+ ion coordination in a functional calcium binding EF 
hand loop. The amino acids used to coordinated calcium within the EF loop are highlighted 
in red with their structures shown [32,65]. 
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Based on the canonical definition of the EF hand loop, aspartic acid is the preferred 
chelating residues at positions 1, 3, 5 and 9 while the carbonyl group of threonine and glutamic 
acid are shown to coordinate Ca2+at position 7 and 12 respectively. These amino acids 
strategically arrange to coordinate calcium in a pentagonal bipyramidal geometry, most 
commonly known as the canonical geometry for EF hand sites [32]. This geometric structure is 
further supported through a network of hydrogen bonds established through the ligands, both 
between and around the EF hand calcium binding loop.  These additional interactions help 
stabilize the unfavorable close proximity of the negatively charged oxygen atoms in the 
coordination sphere of the bound Ca2+ [65].  
Although studies have demonstrated that the coordinating ligands in the EF hand loop 
can vary between species, these sites are shown to continue to bind calcium in a pentagonal 
bipyramidal geometry. This is most likely due to the additional stability achieved in the protein 
structure when the ligands orient on the appropriate axis to coordinate the incoming Ca2+ 
[32,33,48]. 
EF hand proteins that coordinate calcium in geometric arrangements that differ from the 
canonical standards are referred to as non-canonical EF hand loops, and are considered to 
coordinate calcium with a non-canonical geometry.  These EF hand proteins have been shown to 
coordinate calcium in a pentagonal bipyramidal fashion through amino acids that differ from 
those of the canonical loop. In most cases this is a due to an amino acid insertion in the EF hand 
loop, or because the EF loop is shorter than the canonical sequence [65].   
In addition, some EF hands have shown to coordinate Ca2+ with an octahedral geometry, 
although Ca2+ is rarely found to exist in this coordination arrangement in EF hand sites. The 
octahedral geometry is commonly preferred in EF hand sites when binding magnesium ions [65]. 
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This is most likely due to magnesium ion’s smaller ionic radii, which prevents direct 
coordination of the 12th amino acid in the EF hand loop. When aspartic acid is found at this 
position, a water molecule is normally present to bridge and strengthen the interaction between 
the metal ion and coordinating ligand; as a result an octahedral geometry is achieved [65]. 
The geometric coordination arrangement achieved by the EF hand loop depends on the 
canonical amino acids that chelate Ca2+ directly. These residues play a huge role in stabilizing 
and facilitating the folding of the protein structure and are often conserved between species. For 
example, aspartic acid is one of the most highly conserved amino acids of the EF hand loop due 
to its versatile role: it provides both the structural and conformational arrangements of the 
protein needed to interact with calcium ions. Aspartic acid residues most commonly serve as 
coordinating ligands for Ca2+ due to the preference of the EF hand loop for carboxylate ligands 
with a less bulky side chain [75].  
When comparing the amino acid sequences of various EF hand loops from a range of 
species, the aspartic acid at position 1, 3 and 9 remains consistently conserved. At the first 
coordination site (+X position of the pentagonal bipyramidal geometry), the aspartic acid 
provides the precise stereochemical arrangement needed for the protein to properly coordinate a 
Ca2+ ion in the EF hand loop. This arrangement positions the carboxylate oxygen atoms of the 
resides so they are available to interact with various other amino acids within the same loop [65] 
As a result, this creates an extensive hydrogen bonding network within the loop which further 
stabilized the protein structure as it transitions to a calcium bound state [65]. The precise steric 
dimensions of this side chain are pivotal for coordinating calcium in the EF hand loop, as 
previous studies have shown that if an amino acid residue other than aspartic acid present at 
position 1 in the EF hand loop will not bind calcium [32].  
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The overall effects induced on the protein through the different interactions occurring 
between the aspartic acid and the other residues at each position in the loop is due to the position 
of aspartic acid in the loop. Utilizing aspartic acid at these positions provides the most suitable 
environment for the loop to coordinate calcium, and as a result, optimizes the overall function of 
the EF hand [75].  
Another commonly conserved location for Aspartic acid in the EF hand loop is at 
positions 3 (-Y) and 9 (-X). At position 3 the aspartic acid residue interacts with calcium through 
the carboxyl group in the C –terminal and on the R group of the amino acid. This allows the 
aspartic acid residue to fluctuate between a mono-dentate and bidentate ligand to calcium, which 
provides flexibility to the loop and creates a more versatile role in coordinating metal ions.   
Additionally, Aspartic acid is found 23% of the time at position 9 (-X) in EF hand 
proteins. At this position Ca2+ is either chelated directly, or indirectly through a bridged water 
molecule, to the aspartic acid residue. This residue is shorter than glutamic acid, which is also 
found to exist in this position of the EF loop in some species. In order to accommodate the 
smaller side chain of aspartic acid, a water molecule is incorporated into the coordination sphere 
to help bridge the interaction between the loop and the calcium ion. The specific nature of 
residue 9 seems to be one of the major factors that control the rate of Ca2+ binding and release, 
and thus also affinity of the EF hands [64,65].  
Aspartic Acid is also found at position 12 of the loop, but is not preferred at this site. 
Instead glutamate is more commonly found at this position due its larger coordinating group size.  
The small size of the aspartic acid residue creates a large gap between the coordinating atoms of 
the ligands and the metal ion. A water molecule is inserted to bridge this interaction but as a 
result, the affinity and ion selectivity for calcium in the EF hand loop site is significantly 
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decreased [65]. To avoid these effects on the protein, glutamate is most often used as the cleating 
residue at position 12. Glutamate’s larger size allows the coordination atoms come into close 
proximity of the metal ion so that the amino acid can serve as a bidentate side chain ligand in the 
(-Z) plane of the pentagonal bipyramidal geometry of the calcium bound EF hand. As a result, a 
stronger and more stable interaction is achieved in the EF hand loop.  
Threonine is an additional canonical amino acid, most commonly found at the 7th position 
in the EF loop. This amino acid provides the (-Y) part of the coordination geometry where the 
backbone carbonyl is used in chelating Ca2+. It was found through NMR studies utilizing 
paramagnetic lanthanide derivatives revealed that the 7th position in the EF2 loop of CaM had a 
tendency to gain an extra water molecule as a ligand; this coincided with a decreased 
contribution from the main-chain carbonyl group [76]. Ultimately, this ligand exchange results in 
two water molecules in the coordination sphere, which increases the flexibility of the loop [76]. 
The non-chelating amino acids of the EF loop also play a pivotal role in maintaining the 
structural integrity of the EF hand domain. The positions in the loop that do not provide direct 
chelating residues, but are crucial for proper protein folding and arrangement, include positions 6 
and 8. Glycine is highly conserved in EF hands at position 6 of loop, primarily due to its small 
size which facilitates the unusual main chain conformation (φ and ψ angles of 60˚ and 120˚ 
respectively). Upon binding calcium to the EF loop, the presence of glycine enables the 90˚ turn 
which allows the remaining calcium ligands to coordinate. Additionally, glycine, as seen in 
triplet in the N -terminal EF hand loop of sTnC, is more disordered and thus more stable in terms 
of conformational entropic free energy than EF loop II [77,78].  
Ordering EF loop I gives it a 10 fold lower affinity for calcium when compared to EF 
loop II [79].  
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The hydrophobic residue at position 8 [80] is also a highly conserved non-calcium 
chelating amino acid. Its role in the EF hand loop is to participate in the formation of short 
antiparallel β-sheets with the corresponding paired loop’s eighth position. This interaction is 
known as the β-scaffold and will be discussed further in the subsequent section.  
 
1.5.3 EF Hand Pairs and β-Scaffold 
EF hands are normally found to in pairs; they are joined through hydrogen bonding 
interactions that occur between the backbones of the EF hand loops (Figure 5). These 
interactions form local anti-parallel β-sheets, termed the EFβ-scaffold, and are known to serve 
two purposes: stabilize the two EF-hands and govern the Ca2+ induced conformational change of 
the protein (Figure 5). Residues in the –Y position, and the hydrophobic amino acid (Ile, Val, or 
Leu) adjacent to the residue in the –Y position, are known to be involved in the hydrogen bond 
network between the main chain NH and CO groups. This interaction forms the basis of the β-
sheet. In the Ca2+ bound form, stability of the EF hand pair is achieved through the hydrophobic 
interactions occurring between the non-polar amino acids of the alpha helices adjoining the 
calcium binding loop.   
Multiple EF hand pairs are found in various calcium binding proteins. The EF hand pairs 
in these proteins tend to form globular domains [66]. These globular domains can either act 
independently from one another, as in the case of CaM and TnC, or they can be well packed, 
resulting in a single oval shape and act as a cooperative unit as seen in the structure of recoverin 
[81-83].  
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Figure 5. A representation of the molecular interactions occurring between 
two EF hand mates. The hydrogen bond network shown constitutes the β-
scaffold between the two calcium binding loops. Figure adapted from 
reference [84]. 
 
 
1.5.4 The Mechanism of Ca2+ Binding 
A two-step model, termed the EF-hand β-scaffold (EFBS) model, describes the Ca2+ 
binding mechanism [84]. According to this model, Ca2+ first binds to the N-terminus of the loop. 
This ion is held in position because of the structural rigidity of the β-sheet, achieved as a result of 
the relocation of the alpha helices that make up the EF hand motif. This conformational change 
causes the EF helices to form an area of positively charged amino acids, which then polarizes the 
bond network (EF-β scaffold) and facilitates the interaction of the EF-hand mates. As a result, 
stabilization is achieved in the structure of the EF hand pair.   
In the second step, Ca2+ binding to the EF hand loop induces a helical transition between 
the backbone phi and psi angles of the amino acids that make up the EFβ-scaffold. This further 
causes a rotation between the C-terminus of the Ca2+ binding loop and F helix that differs by 
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approximately 2Å [83]. As a result of this shift, the bidentate Glu at position 12 of the loop, is 
close enough to interact with the calcium ion through electrostatic interactions. This further re-
positions the oxygen atom located in the equatorial plane of the Ca2+ ligand complex, and allows 
the calcium ions to coordinate in the loop with the canonical pentagonal bipyramidal geometry.    
The EFBS model describes how the EFβ-scaffold allows two Ca2+ ions to bind to the two 
EF hand domains with positive cooperatively. This is observed in the C-domain of various EF 
hand proteins [66]. When calcium binds to EF hand loops of the C-domain in skeletal TnC, the 
loop closes around the calcium ion as the inter-helical angles of the E and F helices decrease 
from 135° in the apo form to 90° in the Ca2+ bound form. The E and F helices shift from an 
antiparallel orientation to perpendicular relative to one another.  The movement of one EF-hand 
is “felt” through the network of hydrogen bonds by its EF-hand mate. As a result the second loop 
opens which facilitates a calcium ion to bind to that EF hand site.  
This structural transition is highly important for EF hand proteins to carry out their 
appropriate function. This is apparent in troponin C, a muscle regulatory protein that relies on 
this coordinating movement to successfully interact with target proteins in order to maintain and 
control muscle movement [78].   
 
1.6 Troponin C  
Troponin C is a member of the superfamily of EF hand calcium binding proteins [62] and 
participates as the regulatory subunit in a heterotrimeric troponin complex to facilitate muscle 
contraction and relaxation in both skeletal and cardiac muscle. The binding of Ca2+ to TnC 
initiates a cascade of conformational changes through the component proteins of the thin 
filament, leading to the formation of cross bridges (CBs) between actin and myosin and the 
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generation of force by the myocyte. Therefore, the functional properties of TnC, including its 
ability to be activated by Ca2+, have significant regulatory influence on the contractile reaction of 
the myocyte. 
TnC has two EF hand pairs, one at the C domain and one at the N domain as 
demonstrated in Figure 6. The EF hand loops that compose both domains are referred to as EF I 
(Site I) through EF IV (Site IV) where EF I and II (Site II) are located in the N domain and EF 
III (Site III) and EF IV are found in the C domain of TnC. The EF hand loops and their 
corresponding amphipathic helices referred to as helices A and B, C and D, E and F and G and H 
respectively [66], form a four helix bundle with their helices packed together to make a 
hydrophobic core [65]. This hydrophobic region is exposed upon calcium binding to the EF hand 
sites and serves as subsequent binding sites for target proteins. The EF hand sites and 
corresponding helices are shown in Figure 6.   
Connecting both globular domains of TnC is an alpha helical linker region [65]. As 
demonstrated in skeletal and cardiac muscle cells, the helix-loop-helix motif of the EF hands 
allow TnC to act as a Ca2+ sensor whereas the linker region provides a way to relay the calcium 
signal throughout the thin filament [65]. The C and N terminal domains bind calcium with 
different affinities affecting the overall conformational movement between each region of the 
protein. The C-terminal EF loops bind calcium with a high affinity for structural purposes, 
whereas the N-terminal has a lower affinity for calcium as a mechanism of protein regulation 
[52,65].  It is the binding of Ca2+ to the regulatory domain EF sites that induces a change in 
HcTnC conformation that modifies subsequent protein-protein interactions in order to activate 
muscle function.  
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 Figure 6. Structure of full length cardiac TnC showing the C (Left) and N (Right) 
domains of the protein. Each EF hand is labeled as sites I through IV. Both regions are 
separated by a linker regions highlighted in green. The helices corresponding to each EF 
hand are labeled in blue. PDB 1AJ4 [85]. 
 
 
Within a myocyte or muscle cell, TnC is present in complex with Troponin I (TnI) and 
Troponin T (TnT).  The troponin complex is bound to tropomyosin, which is bound to both sides 
of actin along the helical groove.  The orientation of tropomyosin on actin is controlled by 
calcium as it alters the interactions within the troponin complex and among actin and 
tropomyosin Increased intracellular calcium concentration from approximately 100 nm triggers 
the low affinity sites in the N -terminal domain of TnC to bind calcium [54]. This induces a 
conformational change in the N domain of cTnC that partially ‘opens up’ and exposes the central 
hydrophobic cavity of the EF hand pair. This exposed region is thought to strengthen the 
interaction between TnC and the “switch” region of TnI (residues 147–163) [54]. Consequently, 
the interaction between actin and the inhibitory region of the TnI (residues 128–146) decreases 
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[86]. As a result, the inhibitory region of TnI detaches from actin. This change produces 
structural changes in actin [87] that are thought to be important in the regulation of ATPase 
activity.  
In addition, calcium binding to TnC facilitates tropomyosin to move from the inhibitory 
position to the active position on actin. This results in an increased affinity of rigor myosin and 
myosin-ADP binding to actin. Myosin, a hexamer protein composed of 2 heavy chains and 4 
light chains, contains two globular head regions that contain both ATPase activity and actin-
binding activity. The energy released from hydrolysis provides the power needed to facilitate 
muscle contractions. Although the movement of tropomyosin does not have a large effect of 
myosin S1 binding during steady state ATP hydrolysis [88], there is an increase in the kcat for 
actin activated ATPase activity of about 25-fold [89]. Therefore, the strength of these 
interactions between actin and myosin at the actin-binding sites, as well as the rate of CB 
cycling, and the rate of ATP hydrolysis by myosin ATPase [90], together, influence Muscle 
contractility.   
Muscle contraction is an ATP hydrolysis driven, cyclic interaction, of myosin and actin 
[91]. ATP hydrolysis occurs yielding an ADP and Pi molecule when ATP binds close to the 
myosin head projections [91]. Myosin then binds to actin which initiates hydrolysis of ATP, 
thereby releasing a Pi molecule into the cytosol of the cell [91]. The energy released as a result of 
ATP hydrolysis causes the myosin heads to propel the actin back toward the tail of the myosin, 
allowing actin and myosin to slide along each other [91]. Once this process is complete, ADP is 
released from myosin and the head discharges from actin [91]. As long as calcium is present, 
ATP binds once again to the Myosin domain and the process continues. Figure 7 provides a 
26 
 
representation of the proteins units involved in muscle contraction and their relative positions to 
one another under non-calcium conditions. 
 
 
 
 
Figure 7. Representation of the interactions between the regulatory proteins 
involved in cardiac muscle function, under non-calcium conditions. (Filled 
dumbbell) TnC. (Bold Lines) Two TnI helices and the inhibitory region (IR), the 
switch region (SW), and the C-terminal region between residues 164 and 210 (C-
TnI). (Black) TnT helix and the C-terminal region encompassing residues 271–288 
(C-TnT). (Parallel dotted lines) Possible interactions occurring with actin and 
tropomyosin (Tm) when Ca2+ is not bound to TnC, actin is known to be associated 
with the inhibitory, and C-terminal region of TnI, which inhibits specific binding 
sites on actin for myosin. Figure adapted from reference [92]. 
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1.5.1 Skeletal versus Cardiac TnC  
Troponin C serves as an important protein for the regulation of muscle contraction and 
can be found in both skeletal and cardiac muscle. There are distinct differences between sTnC 
and cTnC which make them specific for the tissues in which they reside.  CTnC and sTnC are 
both small (161 and 162 amino acids, respectively) dumbbell-shaped proteins composed of two 
Ca2+ binding EF hand domains separated by an alpha-helical linker [93], both containing the 
same number of  EF hand sites [94].  
The low-affinity NH2-terminal domain contains Ca2+ binding sites I and II, and the high-
affinity COOH- terminal domain contains Ca2+ binding sites III and IV [93]. All of these EF 
hand sites in sTnC bind calcium. However, in cTnC, the first EF hand (loop I) is considered 
nonfunctional; it will not bind calcium due to amino acid sequence substitutions that have 
occurred within the metal binding loop [93]. Comparing the EF I loop sequence with canonical 
EF-hand loop sequences, substitutions of the residues at positions 1 and 3 are replaced by two 
nonpolar residues (Valine and Leucine) that are unable to coordinate Ca2+ ions [95,96]. 
EF hand II, also known as the functional binding site, mimics the loops of the C-domain 
in amino acid sequence and structure of both isoforms allowing Ca2+ to bind.  EF II then serves 
as the sole Ca2+-binding site in N-cTnC at physiological Ca2+ concentrations and acts as the lone 
Ca2+ sensor in the troponin complex for cardiac muscle function [97]. This differs from sTnC 
which utilizes calcium binding in both EF hand sites. Cardiac TnC proteins isolated from other 
mammalian species have also been shown to contain a nonfunctioning (non-calcium binding) 
loop I, which makes this a unique variation for cTnC [93]. The EF hand II of TnC  consists of a 
12-residue loop region [98] which forms a pentagonal bipyramidal arrangement around the Ca2+ 
ion and are at positions X, Y, Z, -Y, -X, -Z [98]. When comparing the functional calcium binding 
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sites in sTnC and cTnC, the metal binding arrangement remains consistent, thereby suggesting 
that this arrangement is native to EF hands and TnC.     
Even though the tertiary structure of the regulatory region of sTnC and cTnC has been 
relatively retained [99] the functional properties of the Ca2+ binding sites of these different 
proteins have been altered through sequence manipulation. In addition to the nonfunctional loop 
in cTnC, the amino acids of the functional loops vary between isoforms. As a result, the two TnC 
analogs have different affinity for Ca2+ ion and are activated by the metal ion differently. For 
example, previous studies involving one-dimensional 1H and two-dimensional {1H,15N}-HSQC 
NMR spectroscopy have demonstrated that the Ca2+ affinity of chicken skeletal NTnC loop II is 
approximately 2 fold the affinity of cTnC human site II [97]. Also, the hydrophobic patch 
exposed following Ca2+ activation with sTnC is 500 Å in area on the surface of the NH2 terminus 
[79].  
In contrast, the hydrophobic patch exposed upon the Ca2+ activation of cTnC is 18 Å 
[79]. This hydrophobic patch does not open to a comparable degree until cTnC interacts with the 
switch region (residues 147–163) of TnI peptide which causes an increase in the opening to 162 
Å [79,86,100]. These results can be attributed to cTnC having only one functional Ca2+ binding 
site (loop II). This causes sTnC and cTnC to demonstrate distinct responses to Ca2+ binding to 
the N-domain. The binding of Ca2+ to loop I in sTnC causes a rearrangement of residue side 
chains that contributes to the enthalpy required to overcome the energy barrier of exposing the 
hydrophobic core [100]. Since this site does not bind calcium in cTnC, comparatively, the 
hydrophobic patch is not as exposed. As a result, cTnC is dependent on the interaction with cTnI 
to facilitate the hydrophobic core to open.  
29 
 
In addition to the differences stated above, cTnI also contains a 32 amino acid (31 in 
human) N’ extension that is absent in the slow skeletal TnI isoform [101]. This extension 
consists of three regions; an acidic N’ region containing a single turn helix, an extended proline 
helix, and a C’ helix containing a bisphosphorylation motif (Ser23/24) [102][103].  
Phosphorylation of these two serine residues by cAMP-dependent protein kinases occurs in 
response to β-adrenergic stimulation of the heart and provides a mechanism to fine tune 
contractile function [104-108].  Effects of bisphosphorylation include a reduced affinity of Ca2+ 
for cTnC [109,110], a reduction of myofilament Ca2+ sensitivity [111], as well as an acceleration 
in cross-bridge cycling [112].   
Studies probing the interaction between cTnI and cTnC have demonstrated that the N’-
extension interacts weakly with the regulatory domain of cTnC, presumably stabilizing more 
open and hence active conformations [113-116]. The proposed binding region of the N’ 
extension occurs between residues 22 to 34 [117,118] while the putative binding site in the N 
lobe of cTnC is localized on the β-sheet bridging Ca2+ binding loops I and II [115,116].  
Phosphorylation at serine residues 23 and 24 appears to abolish binding to N-cTnI [113,115-
117].  
     
1.6.2 Cadmium Binding to Cardiac TnC 
The metal binding sites in EF hand proteins are normally rich in hard base atoms, such as 
oxygen, to provide an environment chemically compatible to coordinate a Ca2+ ion. However, it 
has been noted that these oxygen ligands can be mutated or replaced by residues that contain soft 
base ions such as sulfur [26,56,119]. These variations can effectively decrease the affinity or 
inhibit these sites from coordinating calcium, an example being the previously discussed EF I 
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metal binding site in the N-domain of cardiac TnC. This site is considered nonfunctional, or non-
calcium binding, due to the presence of a cysteine residue located at position 7 of the loop [32]. 
The presence of this cysteine residue makes this site suitable for interactions with soft acid ions 
such as toxic metal, Cd2+.   
The structure of the human N-cTnC domain has been studied extensively by NMR 
[85,86,120,121] but few crystal structures of N-cTnC are available owing to difficulty in forming 
ordered crystals. Cd2+ has been used in these structures provide N-cTnC crystals that diffract to 
high resolution [33]. Through using Cd2+ for crystallization, it has been found that Cd2+ can 
coordinate with Ca-binding proteins, as demonstrated by a recent study that found Cd2+ bound to 
both the regulatory loop, EF II, and vestigial site, EF I, of WT human N-cTnC [52].  
The Zhang lab demonstrated that the EF hand loops, I and II, of the N-terminal in cTnC 
were shown to bind Cd2+. The EF II loop, or functional Ca2+ binding site, is shown to bind Cd2+ 
in a canonical pentagonal bipyramidal geometry with a partially disordered binding loop. This 
distorted geometry is a result of water molecules replacing the coordinating residues Asp67 (Y) 
and Ser69 (Z). The non-metal binding EF -I loop, or the ‘defunct loop’ also binds the Cd2+ ion, 
but does so in a ‘distorted’ octahedral geometry. There is evidence of EF hands having the ability 
to bind calcium in an octahedral geometry, but this is a non-canonical arrangement. However, it 
is usually observed that Cd2+ is bound to non-EF hands with octahedral geometries [33].  
The EF II site in cTnC coordinates Cd2+ in a canonical but distorted pentagonal 
bipyramidal geometry, with four of the ligands coming from Asp65 O(X), Thr71 O (-Y) and 
Glu76 O/O(-Z) and three others from water molecules (-X, Y and Z) (Figure 8). Since two of the 
conserved residues, Asp67 (Y) and Ser69 (Z), are not observed in the electron density (they are 
presumably in a dynamic state), water molecules substitute for the disordered ligands. To our 
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knowledge, this is the first time such an ion coordination has been observed in the N domain of 
cTnC or any other EF-hand protein. This reveals tremendous flexibility in the ion-coordination 
repertoire of this protein. Although NMR data and previous crystal structures have demonstrated 
Cd2+ coordinating in the canonical pentagonal bipyramidal geometry in the EF hand sites of 
Parvalbumin, the C domain sites of sTnC. Figure 2 compares the structures of these proteins, as 
well as the N-Terminal domain of cTnC with Cd2+ bound to the Ca2+ binding sites of the protein.  
The Cd2+ ion located in EF-hand I of cardiac TnC was shown to coordinate with six 
ligands thus leading to a non-canonical, ‘distorted,’ octahedral geometry. Cd2+ is coordinated in 
this manner by binding to the: main-chain carbonyl oxygen of Cys35 (X), oxygen from a water 
(–X), main chain carbonyl oxygen of Asp33 (Y), amino acid residue oxygen Asp33 (Z), sulfur at 
Cys35 (-Y) and acetate (OXT) at the -Z position. The covalent bond formed between Cd2+ and 
the S atom of cysteine is thought to inhibit Cd2+ from dissociating from EF I once it is 
coordinated, thereby indicating a possible irreversible toxic effects of cadmium [32]. 
It has been established that five EF-loop residues at positions 1, 3, 5, 7 and 12 contribute 
coordinating ligands to the calcium ion. However, In EF I of the structure presented here in 
Figure 8, only two residues, Asp33 and Cys35 (positions 5 and 7), contribute to Cd2+ 
coordination. As mentioned, the EF I loop in cTnC does not normally bind ions (vestigial site); 
however, the structure in Figure 8 shows that EF I manages to coordinate Cd2+ by changing the 
loop conformation. This also causes the side chain of the glutamate residue at position 12 to 
change its spatial arrangement. The Glu12 side chain is shown to point away from the 
coordination site and is therefore not available for coordinating Cd2+ in the canonical fashion. 
This feature can be observed by comparing the EF I coordination (listed in Table 3) between the 
N terminal of cTnC with and without bound deoxycholate (DXC). 
32 
 
  
Figure 8. Cadmium coordination in the N terminal EF hand sites of cTnC. Cd2+ 
coordinates in the EF I hand loop in a non-canonical, ‘distorted,’ octahedral 
geometry through interactions with residues Cys35 (X, -Y), Asp33 (Y), and Asp33 
(Z) of the loop as well a water molecule (–X), and a main chain acetate (OXT) (-Z) 
ion. EF II in cTnC  coordinates Cd2+ in a canonical but distorted pentagonal 
bipyramidal geometry. Coordination at this site is achieved with four of the ligands 
coming from Asp65 O(X), Thr71 O (-Y) and Glu76 O/O(-Z) and three others from 
water molecules (-X, Y and Z). Figure adapted from references [32,33]. 
 
 
Other data have verified that EF II in in the N domain of cTnC–DXC and EF II in the N-
cTnC structure presented here both coordinate Cd2+ in the canonical fashion [33]. The two EF 
loops in skeletal troponin C also coordinate Cd2+ canonically [57] leading to the conclusion that 
Cd2+ ions are able to substitute for Ca2+ ions in EF hands in a canonical fashion. Indeed, 
functional data show that Cd2+ can activate skeletal troponin C (in which EF I is functional) by 
substituting for Ca2+ [85,94]. 
By comparing the EFI loop sequences of parvalbumin, calpain, sTnC, cTnC, it can be 
seen that cardiac troponin C is the only one with cysteine as a coordination residue; bear in mind 
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that the cysteine is coordinating a Cd2+ ion in a vestigial ion-binding site, so its significance is 
not clear in a physiological sense. To our knowledge, there is no other example of an EF hand 
protein in which cysteine serves as an ion-coordinating ligand. Interestingly, the NMR structural 
data for cardiac TnC with Cd2+ bound has a similar overall conformation to that observed when 
Ca2+ bound NMR structures [85]. 
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 Figure 9. Crystal structure of HcTnC1-89 highlighting various Cd2+ coordination 
sites (PDB ID 3SD6). (a) Cd2+ ions bound to loop I. Top Cd2+ ion coordinated to 
Cys35 (S and amide O), Asp33 (O δ1 and δ2), 1 Wat, and Acetate.  Bottom Cd2+ ion 
coordinated to Glu40 (O ε1 and ε2), Phe27 (amide O), and 1 Wat. (b) Cd2+ ions bound 
to loop II.  Left Cd2+ coordinated to Glu76 (O ε1 and ε2), Thr71 (O), Asp65 (O δ2) 
and 3 Wat.  Right Cd2+ coordinated to Asp73 (O δ1 and δ2) Asp75 (O δ1 and δ2), and 
Glu66 (O ε2).  (c) Binuclear Cd2+ center bridged by Cys84 (S).  Left Cd2+ bound to 
Asp87 (O δ1) and Gln50 (O ε1).  Right Cd2+ bound to Asp87 (O δ2) and Glu56 (O ε1 
and ε2).  (d) Cd2+ coordinated to Glu59 (O ε1 and ε2) and 3 Wat.  
 
 
Due to its filled d10 orbital shell, and empty f14 orbital, cadmium can easily donate or 
accept electrons from other atoms thereby creating a variety of interactions with surrounding 
molecules. As a result, cadmium can take on a number of different coordination geometries in a 
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variety of metal binding sites, even if those sites are designed to coordinate metal in a specific 
manner.  
Examination of non-EF-hand proteins in complex with Cd2+ reveals that Cd2+ is most 
often coordinated in either tetrahedral or trigonal bipyramidal geometries, with histidine and 
cysteine residues most frequently involved in coordination. It has been reported that Cd2+ was 
also involved in an octahedral geometry using histidine residues as coordinating ligands [122]. 
Other geometries, such as trigonal bipyramidal, have also been observed with Cd2+ coordinating 
through interactions with two cysteine residues, one histidine residue, and two water molecules 
[14,49-51,123,124]. The ionic radius of Cd2+ is similar to that of Ca2+; this similarity in size and 
charge make the two ions competitors for the same protein ion-binding sites [125,126].  
Finally, Cd2+ appears to be more flexible in its coordination number and geometry than 
Ca2+, thus allowing cadmium to accommodate protein conformations in calcium binding sites or 
in sites in which metal binding does not occur. These interactions may impose a threat to the 
function of the protein which in turn could have detrimental effects on the organ system and 
overall health of those organisms with elevated Cd2+ concentrations.  
  
1.6 Project Goals  
Although government regulation has helped control the amount of cadmium emitted into 
the environment and mobilized into food sources, the metal is persistent in the environment due 
to its continued use in manufacturing and its emission due to the petroleum and mining 
industries. Therefore, cadmium toxicity is still a major concern especially for those working in or 
near these industries and smokers. While mechanisms of cadmium toxicity are not known 
exactly, it is known that Cd2+ ion can effectively bind to and displace metal ions from a wide 
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variety of proteins including thiol containing and calcium binding proteins as previously 
discussed.  
As mentioned above, recent crystal structures of Cd2+ bound to the regulatory domain of 
HcTnC (HcTnC1-89) in the free and DXC bound states reveal interesting Cd2+ structures, two of 
which are bound to both Ca2+ binding loops. The most interesting aspect of these was the fact 
that Cd2+ was present in EF hand I loop, a region that does not bind Ca2+.  In light of the potential 
interactions that take place between the regulatory domain and other members of the troponin 
complex such as cTnI, the presence of cadmium at this site may disrupt these interactions.   
It is therefore the goal of this research project to study the interaction between HcTnC 
and Cd2+ carefully by using isothermal titration calorimetry (ITC).  We used ITC to determine 
the thermodynamics (G, H, and S) of Cd2+ binding to both full length HcTnC and the regulatory 
domain, HcTnC1-89.  The data were compared to Ca2+ titrations under identical conditions.  
Further displacement titrations were performed whereby one metal was titrated into protein 
containing the other and vice versa.  Data obtained indicated stoichiometry, and allowed for the 
elucidation of putative cadmium binding sites. 
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 Chapter 2: Experimental Methods 
 
2.1 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) is a useful technique used to determine the binding 
affinity and thermodynamic parameters of a reaction between two or more molecular species. It 
does so by measuring the amount of heat generated or absorbed from each binding event 
occurring between molecules in a given solution. The data obtained from this method is typically 
fit using a mathematical model which further calculates the binding affinity between the two 
molecules, and the thermodynamic parameters stoichiometric ratio (n), binding constant (K), 
enthalpy (ΔH) Gibb’s free energy (ΔG), and entropy (ΔS), of the reaction [127,128]. 
 
 
 
 
Figure 10. A diagram of a typical ITC experiment (Wilcox group, 2008). 
 
 
 
2.2 ITC Instrumentation 
 ITC instruments are designed to efficiently measure the change in heat of a reaction, 
typically between a small ligands and a macromolecule, such as proteins.  The data obtained 
using ITC is primarily achieved through the integrated design of the thermal core region of the 
instrument. Within this region there are two identical cells, known as the reference and reaction 
cell (Figure 10 & 11). These cells are composed of thermal conducting material protected by an 
adiabatic coating, known as the “jacket”. This coating fills the internal space of the instrument 
and contains highly sensitive thermopile/thermocouple circuits which span throughout the entire 
region of the jacket. During a typical ITC experiment, the reaction cell, filled with a solution 
containing a specific protein or biomolecule, is titrated with precise aliquots of a known metal 
solution at specific time intervals throughout the reaction. The reference cell, usually filled with 
water or buffer solution, resides in close proximity to the reaction cell and is kept at a constant 
temperature throughout the duration of the experiment.  
As titrant is added to the reaction cell, the two molecules begin to interact, and as a result, 
heat is either released into (exothermic) or absorbed (endothermic) from the surrounding 
solution. The highly sensitive thermoelectric device spanning the internal region of the 
calorimeter detects these thermal changes by measuring the difference between two separate 
temperature changes (ΔT1 and ΔT2) detected within the thermal region of the instrument.  ΔT1, is 
obtained by measuring the temperature difference between the reference cell and the jacket of the 
calorimeter, while ΔT2 is calculated from the temperature difference detected between the 
reaction cell and reference cell [129,130]. The thermal region of the ITC instrument is shown in 
Figure 11 with the two differences in temperature denoted as ΔT1 and ΔT2, respectively.  
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During the course of a reaction ΔT2 can fluctuate, since the amount of heat consumed/ 
produced from the reaction can change throughout the experiment. Therefore, in order to re-
establish isothermal conditions, whereby the temperature difference between the two cells are 
held constant, the heat source controlling the reaction cell is adjusted accordingly using a cell 
feedback network (CFB) [130]. To elaborate, if a reaction cell produces heat (an exothermic 
reaction), the temperature of the system will increase. The calorimeter will sense this change and 
trigger a decrease in the power source. As a result, the temperature of instrument will decrease 
until isothermal conditions are re-established. The power required to maintain a constant ∆T1 is 
integrated and divided by the total run time to obtain the function of the heat being observed 
[130]. These values are then plotted against time to produce the raw ITC data for a given 
experiment (Figure 12, top graph). 
As the reaction takes place, the amount of heat absorbed or released from the reaction cell 
is measured and plotted on a graph. This energy change can differ with each binding event 
thereby producing a unique set of data points on the graph. For example, as demonstrated in 
Figure 12, a positive peak is observed in the raw data when heat is absorbed, which corresponds 
to an endothermic reaction occurring in the reaction cell. The energy lost during this reaction is 
compensated by an increase in power from the system, thereby resulting in positive peaks in the 
raw data.  However, if heat is lost when the titrant is injected, a negative peak will result thereby 
corresponding to an exothermic heat event.   
This quantity of heat absorbed or released during the mixing process is in direct 
proportion to the amount of binding. Therefore, as the protein reaches metal saturation, the heat 
signal diminishes until only heats of dilution are observed.  The resulting isotherm is fitted using 
a binding model; from the fit, the thermodynamic parameters for the reaction can be obtained. 
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Figure 11. A schematic depicting both the reference and sample cell kept under isothermal 
conditions.   
 
 
2.3 Thermodynamic Parameters 
 ITC is an effective tool used to determine the binding constants and thermodynamic 
parameters of interactions occurring in a solution.  During a typical ITC experiment, a solution of 
small binding molecules is added to an analyte in small consistently portioned aliquots. The heat 
energy resulting after the solutions are mixed, is measured and reported as a peak on the raw data 
graph. These peaks represent a reaction that has gone to equilibrium since the peaks return to 
baseline after each injection. Integrating the peaks obtained from each injection (Figure 12, bottom 
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graph) provides a titration or binding curve of the reaction. Through further graphical manipulation 
the thermodynamic properties associated with the reaction can be extracted from the isotherm.    
The binding affinity of metal to protein, along with the stoichiometry (n) and enthalpy (ΔH) 
of the reaction can be determined by applying a mathematical model to the binding curve from the 
titration.  
From an ideal isotherm, the binding constant, or constants (KB) of a reaction can be 
obtained from the slope of the fitted curve using equation 1. The parameters involved in this 
calculation include M, which denotes the concentration of the macromolecule, and X which 
represents the concentration of the ligand present in solution.  
 
                                  Eq. 1 
The inflection point of the binding isotherm discloses the stoichiometry, n, of the binding 
of the titrant with the analyte while the difference in the heats associated with binding and the heat 
associated with the heat of dilution unveils the ∆H value of the binding.   
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 Figure 12. Representative data depicting an ideal exothermic thermogram.  The raw data 
(top) and fitted binding isotherm (bottom) for a sample ITC experiment. 
 
 
From K and ∆H, one can obtain a complete thermodynamic survey of the binding 
reaction by calculating the Gibbs free energy (∆G), and entropy (∆S) from the following 
equations:  
∆G = -RTln(K)       Eq. 2 
 
∆G = ∆H - T∆S        Eq. 3  
 
The variables include R, T and K which represent the ideal gas constant, temperature of 
the experiment and the binding constant obtained from the slope of the titration curve, 
respectively.  
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The change in Gibbs free energy (ΔG) represents the energy difference of a molecule in 
solution as it transitions from an initial to a final state, and is used to predict the direction and 
spontaneity of a reaction when conditions of a system are set at a constant temperature and 
pressure. A reaction with a negative ΔG is considered favorable/spontaneous and will occur 
without any additional input of energy. On the other hand, a reaction that yields a positive ΔG is 
deemed unfavorable/non-spontaneous and will not occur unless additional energy is added to the 
system. Reactions with a negative and positive ΔG are termed endergonic and exergonic 
respectively.  
As demonstrated by the equation above, ΔG is dependent on the ΔH and ∆S of a reaction; 
these two thermodynamic parameters represent the forces driving a metal-protein complex 
formation [131,132]. Both   ΔH and ΔS not only govern the overall ΔG value but provide a better 
understanding of the interactions occurring in a solution.   
According to the second law of thermodynamics, energy is neither created nor destroyed. 
Therefore, during a reaction, the amount of energy available is proportioned throughout the 
solution until an equilibrium is established.  The amount of energy transferred in a system 
through the formation and dissociation of bonds and intermolecular interactions is referred to as 
enthalpy. When bonds form, heat energy is released into the solvent, resulting in a negative ΔH 
value. The dissociation of bonds, however, require the consumption of heat, which results in a 
positive ∆H.  The strength and amount of interactions can influence the enthalpy value while also 
providing insight into the interactions occurring in solution. For example, a reaction will favor a 
more negative ΔH if the bonds being formed are larger and stronger, than the amount of bonds 
dissociated in solution.  
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The entropy (∆S) of a reaction is another important parameter to consider when 
calculating ΔG and when understanding the mechanism behind a particular binding event as it 
represents the dispersion of energy at a given temperature over microstates during a reaction.  
Processes that contribute to the entropy in a reaction include the hydrophobic effect, electrostatic 
charges, hydrogen bonds, conformational entropy, intermolecular vibrations and changes in 
equilibrium. Although, some of these processes are entropically driven processes, such as the 
hydrophobic effect, while the others, such as conformational entropy, are actual contributors to 
the total entropy. However, regardless the type of entropic process, they can all contribute to, or 
in some cases decrease, the amount of energy dispersed throughout a solution.  
As a result of these effects, the entropy (∆S) will be in either positive or negative. A 
positive value indicates that a favorable tendency towards greater dispersal of energy while a 
negative values represents more ordered systems. For example, the hydrophobic effect facilitates 
the release and further aggregation of hydrophobic residues as a result of protein folding. The 
amount of entropy in the system is initially increased as the protein unfolds but is quickly 
decreased as water molecules form clathrate structures around the exposed hydrophobic residues. 
This caged structure acts to control the random movement of the exposed protein while also 
providing the structural stability needed for the molecule to successfully transitions to a different 
structural state. However, as a result, the entropy becomes more positive. Although, this is not 
always the case. Other entropically favored effects, such as conformational entropy and the 
energy resulting from molecular vibrations, could become greater as a protein transitions its 
structure, and thus provide the solution with an overall negative entropy.  
The analysis of thermodynamic parameters is complex because of the relationships they 
share with one another (Eq. 2 and Eq. 3). Using ITC, several thermodynamic parameters (KB, 
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ΔG, ΔH, and ΔS) for a binding event can be obtained. The parameters will be affected by each 
source differently. Thus, analysis of all the parameters can give insight into each sources 
contribution to the overall thermodynamic driving force.  
 
2.4 ITC Models  
In order to properly analyze the ITC results, the data must be fit using computer software 
installed utilizing a variety of mathematical models. For the purposes of this thesis, The 7.0 
origin software package supplied by MicroCal was used for fitting and analyzing the data 
obtained for this project [130].   
 The raw data obtained from an ITC experiment is opened using the downloaded software 
program, and further fit using a three step process. First, the software makes an initial estimate of 
n, K and ∆H based on the raw data. Then, mathematical binding models installed in the software 
are applied to the data and used to calculate the heat for each injection (ΔQ(i)). As a result, an 
improvement in the initial values of n, K, and ∆H are made using the Marquardt method [130]. 
This Origin® software uses a least square fit to minimize Chi squared (χ2) in the fit of the heat 
flow per injection to an equilibrium binding equation. Included in the Origin® software are 
binding models applicable to a variety of binding interactions. The single site and sequential set 
of sites binding models will be discussed below.  
 
2.4.1 Single Set of Sites  
 The binding of a ligand to a single set of identical sites on a macromolecule is 
represented by the following equilibrium expression, where K is the equilibrium or binding 
constant, Θ is the fraction of sites by which ligand X are occupied, and [X] is the concentration 
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of free ligand in solution.  
 
                  Eq. 4  
 
  The total concentration of ligand, Xt, can be obtained using the equation below. The 
mathematical expression calculates Xt using the [X] and Mt parameters which were previously 
described.   
 
                           Eq. 5            
 
The total heat content, or Q, of the solution contained in Vo can be determined using 
equation 6.  The variable Vo represents the solution at fractional saturation, Θ, and is determined 
relative to zero for the un-complexed species.  
                          Eq. 6 
 Equation 7 is further obtained by combined Eq. 5 and Eq. 6 and rearranging the resulting 
equation to equal 0.   
                    Eq. 7 
 
 After solving for the fractional saturation variable, Θ, using equation 8, the resulting 
value can be entered into Eq. 7 to obtain equation 8.  This mathematical formula can be used to 
find the overall Q(i) for the reaction.  
 
   Eq. 8  
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 The previously calculated values of Xt, Mt, and Vo are entered into the curve fitting 
model prior to fitting the isotherm. However, the n, K, and ΔH in equation 8 are floating 
variables and may change as the curve is fit using the best binding curve parameters.  
  
2.4.2 Sequential Sites  
 In a sequential set of sites binding model, only the total number of saturated sites can be 
determined. Therefore, the binding constants are obtained as the sites become progressively 
saturated and are thus defined relative to the progress of saturation. Equations 9a-c demonstrate 
the binding constant formula for a sequential set of sites with three successive binding events as 
represented by K1, K2, and K3.  
 
                        Eqs. 9a-c 
 
In the equation above, the concentrations of all complexed species [MXi] can be expressed in 
terms of [M]. 
The next set of equations uses the parameter, Fi, to represents the fractional amount of 
macromolecules in solution with i bound ligands. 
 
 Eq. 10 
 
 
                                                                                      Eq. 11 
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                    Eq. 12  
 
 
                                Eq. 13 
 
 For a sequential set of sites, the total concentration of ligand, Xt, can be obtained using 
equation 13 using the parameters [X] and Mt.  
 
               Eq. 14  
  
The binding curve for a set of sequential binding sites can be fit after obtaining the free 
ligand concentration [X] using the bisection numerical method from Eq. 14 through Eq. 13. 
These calculated values are further entered into the Fi equations in order to obtain Q(i) from the 
mathematical equation below.  
         Eq. 15  
 
2.5 Circular Dichroism 
Circular Dichroism (CD) spectroscopy serves as a valuable technique for evaluating the 
conformational changes in the secondary and tertiary structure of proteins and biomolecules. 
This technique works by measuring the difference in absorption between left-handed circularly 
polarized light and right-handed circularly polarized light of an optically active medium. Proteins 
and large biomolecules contain chiral chromophores which absorb circularly polarized light. The 
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amount of left or right handed circularly polarized light absorbed by these groups can vary 
depending on the conformation of the protein, which is easily affected by small environmental 
changes.   
Therefore, CD spectroscopy serves as a useful tool to investigate the secondary structure 
of proteins and other biomolecules, both in their native state and when subjected to changes in 
environmental conditions, such as temperature, pH, or interactions with other molecules and 
ions. The data obtained from CD spectroscopy can be combined with other protein structural 
analysis methods such as X-ray crystallography or NMR to further evaluate or confirm the 
integrity of expressed domains of a multi-domain protein under normal and altered conditions.  
 
2.5.1 Circular Dichroism Theory 
The method behind CD spectroscopy is based on the differential absorption between left 
and right circularly polarized light. However, in order to understand how light is circularly 
polarized in CD for structural analysis, one must first understand the basics of polarization.  
 Light sources emit electromagnetic waves which are composed of oscillating electric and 
magnetic fields. These fields propagate perpendicularly to each other and to their direction of 
travel. When these fields oscillate in various directions, the light waves emitted are considered to 
be non-polarized. However, light can be polarized by manipulating the direction of the electric 
field vectors of a light wave. For example, linear polarized light is achieved when the electric 
fields are fixed to oscillate in a single plane concurrent with the direction of propagation.  
Circular polarized light, on the other hand, is a type of polarized light that results when the 
electric fields of a light wave are manipulated to propagate in a helical fashion around the axis of 
propagation.  Two polarized light waves when combined, can also produce linear and circular 
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polarized light. Manipulating two polarized light waves to be in phase with each other at 90° will 
result in linearly polarized light, as shown in Figure 13 (AI) [133].  
If one of the polarized light waves are positioned out of phase with the other by 45°, the 
resultant wave ceases to be linearly polarized and instead is projected as a helix. This helical 
shape of light is known as circularly polarized light (CPL) and propagates in either a right-
handed (RCPL) or left-handed (LCPL) direction, see Figure 13 (AII).  
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 Figure 13. A schematic represention of circular polarized light. (A) A representation of  
circular polarized light when the components of plan polarized, left (L) and right (R) 
circular polarized light waves, are at equal (I) and unequal amplitudes (II). The 
resultant radiation is plane polarized light (I) and elliptically polarized light (II: dashed 
line), respectively. (B) The amount of L and R circularly polarized light absorbed by a 
sample determines the CD spectra produced, which depends on the secondary structure 
of the molecule in solution.  A positive CD spectra is observed when more L (band 1) is 
absorbed. A negative CD spectra is obtained when more R (band 2) waves are 
absorbed. When equal amounts of L and R light are absorbed by a solution (ex. achiral 
solution), band 3, no CD spectra is observed. Figure adapted from reference [133]. 
 
 
RCPL and LCLP waves are non-superimposable; in other words, CPL is chiral. This 
characteristic means that right versus left CPL waves are, by definition, enantiomers and differ 
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from each other in how they interact with other enantiomeric species. Therefore, when an 
optically active solution is subjected to CPL, the RCPL and LCPL waves will interact differently 
with the chiral species of the sample. As a result, unequal amounts of RCPL and LCPL are 
absorbed by the molecules in solution. The difference in RCPL and LCPL can be measured and 
recorded as the ellipticity. This differential calculation mathematically defines circular 
dichroism.   
 
2.5.2 Chiral Molecules 
Samples containing chromophores are able to absorb light at different extents but are 
wavelength specific. A chromophore is referred to as a region or group within a molecule that 
will absorb electromagnetic energy within a particular wavelength range. However, in order to 
absorb CPL, a molecule of interest, subjected to the absorption wavelength range, must contain 
chromophoric regions or be present in an optically active asymmetric environment.  
Due to the difference in absorption of a chromophoric solution, the resulting radiation 
will be detected as elliptical polarization.  CD instruments (known as spectropolarimeters) 
measure the difference in absorbance between the L and R circularly polarized components 
(DA=ALAR). This difference can be converted to ellipticity (𝜃𝜃) in degrees, which is the 
common measurement reported in chemical CD studies.  
 
2.6 Instrumentation  
Circular dichroism spectroscopy measures the difference between right and left polarized 
light absorbed by a sample of interest. In order to obtain such measurements, CD spectroscopy 
utilizes a sophisticated spectrometry technique designed to manipulate monochromatic linearly 
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polarized light into circularly polarized light and further detect and plot the differential signal.  
The general components of a CD spectrometer include: a high intensity light source, 
which usually emits light in the UV range (170-300 nm), a monochromator, a photo-elastic 
modulator (PEM), a lock-in amplifier, and a detector [133].  
A CD spectrometer works by first initiating the light source located within the instrument 
to emit a stream of non-polarized light. This light is projected into the monochromator which 
polarizes the light into one wavelength specific for the sample. After leaving the 
monochromator, the linearly polarized light waves reach a photo elastic modulator (PEM) where 
it is further converted into left and right circularly polarized light waves.  
The PEM is a specialized optical component known as a piezoelectric element. This 
element is cemented to a block of used silica that can oscillate at a resonance frequency, 
normally set at 50 kHz. When oscillating, the level of stress is induced upon the silica component 
which causes it to become birefringent [133]. The oscillating piezoelectric element induces 
alternating stress in the fused silica plate, thereby resulting in a dynamic quarter-wave plate.  
The vertical component of the incoming linearly polarized light is slowed by a quarter-
wave with respect to the horizontal component of the wave. The alternating silica plate then 
shifts to interact with the horizontal vectors, further slowing those light waves by a quarter 
degree respective to the vertical component of the polarized wave. The dynamic movement of 
the silica plate by a quarter wave produces left and right circularly polarized light that oscillates 
at the appropriate frequency.  In order to successfully polarize the wavelength of light entering 
into the silica block, the amplitude of the oscillations can be changed. Light waves leaving the 
PEM are circularly polarized and will enter into the sample as equal amounts of left and right 
circularly polarized light. If no sample is present, equal amounts of RCPL and LCPL will result 
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in a linearly polarized light wave which the detector recognizes and reports as a steady signal on 
the output system. However, if an optically active sample is present, RCPL and LCPL will be 
absorbed in different amounts.  
The resultant light that reaches the detector produces a signal that varies with PEM 
frequency [133]. A lock-in amplifier tuned to the PEM frequency measures the difference in 
intensity of the left and right components of the circularly polarized light. The average light 
intensity over time is measured as voltage direct current (vDC). This value is then used to scale 
the changes in CD measured by the voltage alternating current (vAC) signal [133].  The 
calculation used to obtain CD values, in units of millidegrees or change in absorbance, is 
demonstrate in equation 16. This value is obtained by dividing the vAC by the vDC signal 
followed by multiplication of the calibration factor (G).  
𝐶𝐶𝐶𝐶 = 𝑣𝑣𝑣𝑣𝑣𝑣
𝑣𝑣𝑣𝑣𝑣𝑣
∗ 𝐺𝐺       Eq. 16  
The obtained ellipticity or ΔA is plotted vs wavelength of light to give the observed CD 
spectra. It should be noted that in most biological studies, the observed CD signals are very 
small, i.e., ellipticities are typically in the range 10 millidegrees, corresponding to a difference in 
absorbance. It is therefore especially important in CD work to pay attention to the experimental 
conditions in order to ensure that meaningful data are obtained [133]. 
 
2.7 Protein Structure Identification  
 An advantage of the CD technique in studies of proteins is that complementary structural 
information can be obtained from a number of spectral regions [133]. 
Spectral bands are easily assigned to distinct structural features of a molecule. In proteins, the 
chromophores, which absorb light include: the peptide bond (240 nm), aromatic amino acid side 
55 
 
chains (260 to 320 nm), and disulfide bonds which produce a weak broad absorption bands (260 
nm). Chromophores absorbing around 240 nm and below is principally due to the peptide bond. 
However, there is sometimes a weak but broad transition centered on 220 nm and a more intense 
transition around 190 nm that occurs when peptide bonds absorb light [134,135].  
The conformational arrangement of some molecules does not always expose these 
chromophore regions which can alter the absorption pattern of the molecule.  Larger molecules 
are composed of regular secondary structures, such as alpha helix, beta sheet, and random coils; 
these give rise to characteristic and identifiable CD spectra in the far UV (Figure 14). Therefore, 
these patterns are referenced when studying larger biomolecules using CD.  
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Figure 14. CD spectra representing the structural curves for protein solutions 
consisting of mostly alpha helices (—), anti-parallel beta sheets (———), type I 
beta-turn (—••—), extended alpha-helix or poly (Pro) II helix (—•—), or random 
coiled structures (•••). Figure adapted from reference [134]. 
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 Chapter 3: Cd2+ Binding to the Full Length HcTnC 
 
Thermodynamic and CD spectroscopy studies were performed using purified full length 
HcTnC. The thermodynamics of cadmium binding to full length HcTnC were obtained and 
compared to the data from Ca2+ binding to full length HcTnC. Our studies provide binding 
affinities and stoichiometries of Cd2+ and Ca2+ binding to the protein and will allow us to 
determine if Cd2+ can displace Ca2+ under our conditions. This information may also infer where 
Cd2+ is binding on HcTnC, thereby providing preliminary information regarding possible 
mechanisms of cadmium toxicity at the molecular level.  Previous studies have indicated that 
Cd2+ can bind to the EF II and the EF I loop of cTnC while NMR data suggest that Cd2+ binds to 
the C-domain of cTnC and induces structural transition similar to those observed when Ca2+ 
binds to the C-domain site of the protein. Through our experimental investigation of Cd2+ 
binding to full length cTnC we suggest that Cd2+ is binding to the C-domain and at a site other 
than EF II in the N domain. Our findings are presented and discussed below.  
 
3.1 Experimental 
The recombinant pET3d plasmid containing the gene for HcTnC was generously donated 
by the Chalovich lab at the Brody School of Medicine. The plasmid was expressed in the 
BL21(DE3) pLysS host strain of Escherichia Coli. The procedure used for protein expression 
and purification of full length HcTnC is described in Appendix A. 
The Ca2+ and Cd2+ stock solutions for ITC and CD experimental analysis were prepared 
from atomic absorption standards purchased from Ricca chemicals. Metal stocks contained 5 
mM calcium or cadmium, 50 mM Bis-Tris, 100 mM KCl at pH = 7.0 and were stored at room 
 
 
temperature.  In the preparation of all buffers, 18 MΩ water was used and reagents were 
purchased from Sigma-Aldrich as more than 99% pure unless otherwise mentioned.   
 
3.2. Titrations of Ca2+ into full length HcTnC  
Figure 15 shows a representative binding isotherm for the titration of Ca2+ ion into apo 
HcTnC.  The thermogram displays two binding events at molar ratios of n=2 and n=3. The data 
presented in Figure 15 is very similar to data described by Skowronsky et al. but under different 
buffer conditions [132] and is therefore the second instance where binding of Ca2+ to the N-
domain has been observed.  
The first binding event at n=2 is highly exothermic and is represented by the negative 
peaks shown in the raw data of Figure 15 and by the negative enthalpic value (∆H = -4.5 (± 0.1) 
kcal/mol) in Table 2. This binding event represents the first two Ca2+ ions binding to the protein. 
The tight inflection point and large K value of 5 (± 2) ×106 obtained from fitting the data, is 
consistent with the binding of the structural Ca2+ ions to the C-domain of the protein. The second 
binding event at n=3 is endothermic and is represented by positive peaks in the raw data (top 
graph) of Figure 15, and by a positive change in enthalpy (∆H = 1.3 (± 0.2) kcal/mol) in Table 2. 
The weak inflection and smaller K value of 5.0 (±0.4) ×104 is consistent with the third Ca2+ ion 
binding to the regulatory or N-domain of HcTnC.  
It is important to note that the K values observed are buffer and pH dependent values.  
Because Bis-Tris buffer binds to Ca2+ with a weak affinity [136], this must be taken into 
consideration in order to obtain buffer independent metal binding values.  After adjusting for 
buffer according to previously published methods from our lab [132], the binding affinity 
associated with both the exothermic and endothermic events are 4 (± 2) x107 and 3.8 (± 0.3) ×105 
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respectively (Table 2). These values are on the same order of magnitude as those previously 
reported in the literature [127]. 
Calcium ion binding to HcTnC occurs with positive cooperativity due to the hydrogen 
bond network located between EF-hand mates [34]. The data were therefore fit to a sequential 
binding model which assumes that binding of the first ligand or metal is followed by the second 
etc. Because the first and second Ca2+ ions bind in a single thermodynamic event, the binding 
parameters for these two ions were set equal to one another. The thermodynamic parameters 
obtained from fitting the data are listed in Table 2. Binding of the first two Ca2+ ions occur with a 
favorable Gibbs free energy (-9.0 ± 0.3 kcal/mol) and a favorable T∆S (4.5 ± 0.3 kcal/mol).    
 
3.2.1 Thermodynamics of Ca2+ binding to C-domain of HcTnC 
The binding of calcium to the C-domain is both enthalpically and entropically driven 
based on the respective negative ∆H and positive ∆S values shown in Table 2. These 
thermodynamic parameters are mostly a result of a series of interactions that occur within the 
protein as it transitions to a more folded structure upon binding calcium in the EF hand sites of 
the C-domain. Ca2+ binding to the C-domain of HcTnC induces a small structural shift in the 
protein which positions the amino acids, outside of the EF loop, closer together. This facilitates 
further electrostatic and hydrophobic interactions to occur within the protein structure, and as a 
result, a large amount of heat energy is produced. This heat energy not only gives an overall 
negative enthalpy, thereby making this event enthalpically favorable, but serves as the driving 
force in the transition of the protein from an unfolded to a more folded structure.  
 The interactions induced from calcium binding to the C-domain also increases the 
entropy of the system by releasing water molecules into the surrounding solvent. Clathrate water 
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molecules are usually found surrounding the hydrophobic residues in the C-domain of HcTnC. 
Calcium binding to the C-domain EF hand sites facilitates these non-polar amino acids to 
aggregate, which releases the bound water molecules into the solvent. As a result the entropy of 
the system is increased. Calcium binding through positive cooperativity to the C-domain also 
releases energy into the system, thereby, contributing to the overall favorable entropy value. The 
second loop of the C-domain has a more organized conformation as a result of the first Ca2+ 
binding. This puts a strain on the structure of the protein but is relieved when the second Ca2+ 
binds to the EF hand site. This interaction increases the degrees of freedom within the molecule 
and as a result, a larger amount of entropy is released into the system. Previous calorimetric 
studies have also shown that binding of Ca2+ to the C-domain of Bovine cTnC have also shown 
to be enthalpically and entropically favorable for similar reasons [34,127]. 
 
3.2.2 Thermodynamics of Ca2+ binding to the N-domain of HcTnC 
Ca2+ binding to the N-domain occurs spontaneously with a ∆G of -6.4 (± 0.1) kcal/mol 
and is entropically driven based on both the positive ∆H of 1.3 (± 0.2) kcal/mol and ∆S of 7.7 (± 
0.2) kcal/mol (Table 2).  However, it is important to note that after accounting for the buffer 
contributions to binding, the enthalpy becomes negative [132], although not nearly as exothermic 
as the first binding event.  This is because Ca2+ binding to the N-domain does not induce a 
conformational change that is as large as that observed in the C-domain. In fact, the NMR 
structures of both the apo and holo N-domain proteins are very similar [85,137]. Calcium 
binding to the regulatory domains of wheat germ calmodulin and skeletal troponin C at 25 °C 
and pH=7.0 have also been observed as entropically driven processes [138].  
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Figure 15. Representative ITC data of 1.5 mM Ca2+ titrated into 0.065 mM 
HcTnC.  All samples are in 50 mM Bis-Tris (pH 7.0) and 100 mM KCl at 
25 °C. Thermodynamic data are listed in Table 2. 
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Table 2.  Best fit thermodynamic parameters and corrected values for Ca2+ binding to 
apo and Cd2+ saturated HcTnC. Thermodynamic values (∆G, ∆H and ∆S) are reported 
in kcal/mol.   
 
 
 
 
 
 
 
 
 
 
 
 
a. Corrected Kb values are adjusted for buffer (Bis-Tris) at pH = 7.0 
and ionic strength of 0.05 M. 
 
3.2.3. CD Studies of Ca2+ binding to full length HcTnC 
In addition to ITC, a study involving circular dichroism was performed to demonstrate 
the structural effects of calcium binding to HcTnC. The CD results in Figure 18 demonstrate that 
calcium binding to HcTnC produces a large molar ellipticity at 222 nm, which indicates an 
increase in alpha helical content of the protein. This is mostly due to the structural changes that 
occur in the C-domain when binding calcium as there is little change in structure in the N-
domain upon Ca2+ binding as noted by NMR studies on the truncated form of the protein 
[85,137].  CD data obtained from skeletal TnC also support these findings, showing the majority 
of the 73% of structural changes occurring from Ca2+ binding to the C domain [139]. 
3.3 Thermodynamics of Ca2+ titrated into Cd2+ bound HcTnC  
Figure 16 shows a representative thermogram for Ca2+ titrated into Cd2+ bound HcTnC 
after background subtraction. This single thermodynamic event is endothermic based on the 
 Apo HcTnC Correcteda Cd
2+ bound  
HcTnC Corrected
a 
K(1=2)  5 (± 2) ×106 4 (± 2) ×107 2 (± 1)×104  1 (± 1)×105 
∆G(1=2) -9.0 (± 0.3)  -5.6 (± 0.5)  
∆H(1=2) -4.5 (± 0.1)   5 (± 3)  
T∆S(1=2) 4.5 (± 0.3)  10.6 (± 3.0)  
K3  5.0 (± 0.4) ×104 3.8 (± 0.3) ×105   
∆G3 -6.4 (± 0.1)    
∆H3 1.3 (± 0.2)    
T∆S3 7.7 (± 0.2)    
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positive peaks shown in the isotherms of Figure 16 and the positive enthalpy values listed in 
Table 2.  The isotherm also appears to represent one Ca2+ ion binding to protein. While it is not 
clear where the inflection occurs upon first inspection, fixing the n value to 1 in the fitting 
procedure yielded values with the least chi2 and errors. The binding affinity for this event is 2 (± 
1) ×104 and 1 (± 1) ×105 when corrected for buffer contributions.  
The interaction between Ca2+ and Cd2+ bound HcTnC is spontaneous and occurs with a 
∆G = -5.6 (± 0.5) kcal/mol. The positive ∆H and ∆S values of 5 (± 3) and 10.6 (± 3.0) kcal/mol 
as listed in Table 2 indicate that Ca2+ binding under such conditions is an entropically driven 
process. This is similar to the binding of Ca2+ to apo N-domain of HcTnC (ΔG = -5.6 kcal/mol0 
with the enthalpy and entropy of Ca2+ binding in this case being more positive by 3.7 and 2.9 
kcal/mol respectively.  
Although ITC studies alone cannot determine where the calcium ion is binding, the very 
similar ΔG’s of calcium binding between apo and cadmium bound protein (ΔΔG =│0.8 
kcal/mol│) indicate that Ca2+ is capable of binding to the N-domain of HcTnC even in the 
presence of Cd2+.  The different ΔS and ΔH values suggest that Cd2+ has altered the binding of 
Ca2+ to the protein. CD studies suggest the presence of Cd2+ alters the structure of the Ca2+ bound 
protein slightly (see below) which may explain the differences observed in ∆H and ∆S.  More 
studies need to be done to determine if cadmium has an effect on the interaction of HcTnC with 
other troponin proteins.   
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Figure 16. Representative ITC data of 1.5 mM Ca2+ titrated into  0.047 mM 
HcTnC containing 0.27 mM Cd2+. The blue line represents the Ca2+ into buffer 
plus Cd2+ (0.27 mM) background.  All samples are in 50 mM Bis-Tris (pH 7.0) 
and 100 mM KCl at 25 ˚C. Thermodynamic data are listed in Table 3. 
 
 
3.4 Thermodynamics of Cd2+ titrated into apo HcTnC 
The isotherm in Figure 17a represents the titration of Cd2+ into apo HcTnC. The data 
appear to consist of one thermodynamic event, but is best fit to a “sequential set of sites” model 
that accounts for three Cd2+ ions binding to the protein. The first event observed in Figure 17a is 
exothermic and is represented by negative peaks in the raw data (top graph) of Figure 17a and by 
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the negative enthalpy values listed in Table 3.  The first event is shown by a sharp inflection at 
molar ratio of n=2 which indicates that two Cd2+ ions are binding for every one mol of apo 
HcTnC.  
The binding parameters for both Cd2+ ions cannot be resolved in the data and are 
therefore are represented by a single binding affinity of 1.6 (± 0.1) ×108 and an enthalpy of -13.7 
(± 0.1) kcal/mol. The Gibbs free energy for the first two Cd2+ ions binding to the protein is 
energetically favorable with a ∆G1=2 equal to -9.8 (± 0.1) kcal/mol.  This process is enthalpically 
driven, as the TΔS is negative kcal/mol and not favorable and is analogous to two Ca2+ ions 
binding to the C-domain of the protein.  
Our data do not indicate where these Cd2+ ions are binding, however previous 1H NMR 
studies reveal that the addition of two equivalents of Cd2+ to bovine cardiac TnC produces a 
spectrum that is identical to that obtained when two equivalents of Ca2+ are added to the protein 
[140] thus suggesting that binding is occurring to the Ca2+ binding loops of the C-domain. In 
addition, 113Cd NMR experiments reveal that the two cadmium equivalents bind with very high 
affinity and that just as in the case of Ca2+ binding to the C-domain of HcTnC, these two Cd2+ 
ions are thought to bind with positive cooperativity. NMR structures of full length skeletal 
HcTnC also reveal the presence of two Cd2+ ions bound to the C-domain of the protein only [56]. 
Taken together, we believe the two high affinity Cd2+ ions seen in our ITC data are binding to 
the C-domain of HcTnC, displaying a single thermodynamic event consistent with two Cd2+ ions 
binding with one Ka and heat exchange of ∆H1 + ∆H2. These Cd2+ ions bind an order of 
magnitude more tightly than Ca2+ and are capable of competing with Ca2+ for these two sites.  
The second binding event represents a third Cd2+ ion binding to apo HcTnC. This 
thermodynamic event is exothermic and is depicted by small negative peaks located close to the 
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baseline in the raw data of Figure 17a and by the negative enthalpy values obtained in Table 3.  
The binding affinity for the binding of the third Cd2+ is 4 (± 3) ×105 and has an enthalpy of -1.3 
kcal/mol.  This event is also spontaneous, occurring with a ∆G of -6.2 (±0.4) kcal/mol and a very 
favorable ∆S (4.9 kcal/mol).  
Recent crystal structures of Cd2+ bound to the regulatory domain of HcTnC in the 
presence and absence of deoxycholate [32,33] did show Cd2+ ion binding to both EF hand loops I 
and II. We believe that the second binding and much weaker binding event corresponds to the 
third Cd2+ ion.  Because Ca2+ appears to bind to loop II in the Cd2+ saturated state with similar 
Gibbs free energy as the apo scenario, we propose that the third Cd2+ ion observed in our ITC 
thermogram is possibly binding to the defunct EF hand (loop I).   
While previous 1H-NMR studies comparing Ca2+ and Cd2+ binding to bovine cTnC did 
display slight differences in spectra after the addition of 3 equivalents of metal, 113Cd NMR 
could not detect the binding of the third ion. If bound to the defunct loop, Cd2+ forms a thiolate 
bond with the cysteine residue present in the loop. The resonance signature for this thiolate bond 
in 113Cd would be present at ~600 ppm and would be difficult to detect without 113Cd 
enrichment.  Although more studies are necessary, our current model based on the current 
thermodynamic study is that Cd2+ is binding to the defunct loop of HcTnC. 
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 Figure 17. Representative ITC data of (a) 1.5 mM Cd2+ titrated into 0.041 mM apo HcTnC 
and (b) 1.5 mM Cd2+ titrated into 0.043 mM HcTnC containing 0.27 mM Ca2+.  All 
samples are in 50 mM Bis-Tris (pH 7.0) and 100 mM KCl at 25 ˚C.  Thermodynamic data 
are listed in Table 3. 
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Table 3. Best fit thermodynamic parameters for Cd2+ binding to apo and Ca2+ bound 
HcTnC. Thermodynamic values (∆G, ∆H and ∆S) are reported in kcal/mol.   
a. Corrected Kb values are adjusted for buffer (Bis-Tris) at pH = 7.0 and ionic 
strength of 0.1 M. 
 
 
3.5. Thermodynamics of Cd2+ binding to Ca2+ saturated HcTnC  
 Figure 17b is a representative thermogram of Cd2+ titrated into Ca2+ saturated HcTnC. 
The thermogram is very similar to Cd2+ titrated into apo protein with two ions binding in a single 
exothermic event at n=2 and a subsequent exothermic event at n=3. The data were best fit to a 
“set of sequential sites” model with n=3 sites. The binding affinity for the first event is 3 (±1) x 
107 which is within error of the first two Cd2+ ions binding to apo HcTnC. The ΔG of this event 
is -10.1 kcal/mol and occurs spontaneously as a result of enthalpically and entropically favored 
events. While the overall Gibbs free energy is similar to the apo scenario, closer inspection of the 
enthalpy and entropy of binding reveals key differences. The enthalpy of Cd2+ binding has 
become more disfavored by 4.6 kcal/mol while the entropy has compensated by becoming more 
favored by 4.9 kcal/mol. 
 Apo HcTnC Correcteda  Ca2+ bound  HcTnC Correctedb 
K1=2  2.0 (± 0.1)×107 1.6 (± 0.1)×108  3 (± 1)×107 3 (± 1)×108 
∆G1=2  -9.8 (± 0.1)  -10.1 (± 0.2)  
∆H1=2 -13.7 (± 0.1)  -9.1 (± 0.7)  
T∆S1=2 -3.9 (± 0.1)  1.0 (± 0.3)  
K3  4 (± 3)×104 4 (± 3)×105 1.3 (± 0.2)×104 1.4 (± 0.2)×105 
∆G3 -6.2 (± 0.4)  -6.0 (± 0.2)  
∆H3 -1.3 (± 0.2)  -3.1  (± 0.5)  
T∆S3 4.9 (± 0.4)  -2.9 (± 0.5)  
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 A comparison of the binding constants obtained from the Ca2+ and Cd2+ binding to apo 
HcTnC reveal that Cd2+ binding is an order of magnitude larger than Ca2+.  This indicates that 
Cd2+ is capable of displacing the first two Ca2+ ions from the protein. A simple displacement 
model using the following equation, KCd apparent = KCd/(Kca x [Ca]), suggests that this 
displacement would occur with an apparent binding constant of ~4 x 103.  This is not observed in 
our thermodynamic titration therefore indicating that metal displacement is occurring via a 
different mechanism. It is important to note that the first two Ca2+ ions bind with positive 
cooperativity where the first Ca2+ ion triggers a structural change that allows the second metal 
ion to bind with a much higher affinity.  The result is that both ions saturate with a single Ka 
value and heat exchange of ∆H1 + ∆H2.  In terms of displacement, the first Cd2+ ion displaces 
the more weakly bound Ca2+ ion (the first Ca2+ to bind the protein). To better describe our 
thermodynamics, we believe that the binding of the first Cd2+ ion to Ca2+ ion site 1 weakens the 
binding of the second Ca2+ thereby allowing the second Cd2+ to bind to the protein with a high 
affinity.  The result is that the two Cd2+ ions bind to the protein with a single thermodynamic 
event, with Ka’s similar to the apo scenario, and a heat exchange of ∆H1 + ∆H2.       
The second thermodynamic event is exothermic and is depicted by small negative peaks 
located close to the baseline in the raw data of both isotherms in Figure 17 and by the negative 
enthalpy values obtained during each titration.  The binding affinity of 1.4 (± 0.2) x 105 
represents the third Cd2+ ion binding to calcium saturated HcTnC and is similar to the apo 
scenario with a Gibbs free energy of -6.0 (±0.2) kcal/mol.  Again the enthalpy and entropy of 
binding is different with the enthalpy becoming disfavored by 1.8 kcal/mol and the entropy 
becoming more favored by 7.8 kcal/mol. If the third Cd2+ is binding to the defunct loop, our data 
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suggests that Ca2+ present in the functional loop does not have a major impact on the overall 
Gibbs free energy but does effect the enthalpy and entropy slightly.  
 
3.6. CD studies of Ca2+, Cd2+, and Ca2+/Cd2+ bound HcTnC 
The CD spectra of apo, Ca2+, Cd2+, and Ca2+/Cd2+ bound HcTnC are displayed in Figure 
18. Notable differences are apparent when comparing representative CD spectra of apo HcTnC 
to the Ca2+ and Cd2+ bound forms. The graphs show that both Ca2+ and Cd2+ ions are capable of 
inducing secondary structural changes upon binding albeit with a few differences.  It is important 
to note that these differences are not due to simple concentration differences as they cannot be 
explained by scaling of the spectra.  These changes are most notable at 209 and 222 nm, the 
spectral region that corresponds to alpha-helical structure, and are most dramatic for Ca2+ ion 
binding. This spectral changes are more dramatic for Ca2+ than Cd2+ ion and as discussed 
previously, these large changes in ellipticity are due to structural changes that occur in the C-
domain as a result of metal ion binding [139].  The large changes in ellipticity observed upon 
Cd2+ binding provide further support that cadmium is indeed binding to the C-domain.   
Even more interesting, the spectrum representing the mixed metal species (Ca2+/Cd2+) 
resembles that of the Ca2+ bound protein with a minor difference in ellipticity centered at 220 
nm.  This indicates that the structure obtained from Cd2+ binding to apo protein is very different 
from the structure obtained when Cd2+ displaces Ca2+ from the protein and can perhaps be 
explained by a model that invokes metal ion cooperativity (see discussion above).  
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 Figure 18. Circular dichroism data of ( ) 0.02 mM apo HcTnC, ( ) 2 mM Ca2+ 
plus 0.02 HcTnC, ( ) 2 mM Cd2+ plus 0.02 mM HcTnC, and ( ) 2 mM Ca2+ and 2 
mM Cd2+ plus 0.02 mM HcTnC1-89.  All samples are in 10 mM Bis-Tris (pH 7.0) and 10 
mM KCl.  Data were collected at 25 ˚C.   
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3.7 Conclusions 
In conclusion, our thermodynamic studies indicate that a total of three Cd2+ ions bind to 
HcTnC. The first two high affinity Cd2+ ions appear to bind to the protein with a single 
thermodynamic event and binding affinity that is an order of magnitude larger than Ca2+.  
Previous studies probing Cd2+ ion binding to bovine cTnC using 1H and 113CD NMR suggest that 
both Cd2+ ions bind to the C-domain. This is supported by our CD studies which show large 
structural changes indicative of metal ion structural reorganization to the C-domain.   
The third Cd2+ ion binds to the protein with an affinity that is ~2 orders of magnitude 
smaller than the high affinity metal ions. While previous NMR structures demonstrate the ability 
of Cd2+ to bind to both EF hand loops I and II, our studies suggest that Cd2+ has a preference for 
loop I (the defunct loop) under our conditions. More specifically, our ITC studies show that Ca2+ 
ion binding to HcTnC in the presence of Cd2+ occurs with a Gibbs free energy that is similar to 
the binding of Ca2+ to the N-domain.  In addition, the third Cd2+ ion binds to the apo protein with 
a Gibbs free energy that is similar to binding in the presence of Ca2+ thus indicating that both 
ions bind to different loops in the protein. The slight differences in enthalpy and entropy indicate 
that the presence of metal at one site alters the structure or conformation of metal at the other site 
thus indicating communication between the two EF hands.   
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 Chapter 4: Cd2+ Binding to the N-Domain of HcTnC 
 
A recent crystal structure reported several Cd2+ ions binding to the regulatory domain of 
HcTnC (HcTnC1-89).  Two of these ions were located in EF hands I and II and with geometries 
similar to Ca2+. In this study, we utilized ITC and CD to characterize the thermodynamics and 
structures of Cd2+ binding to the isolated N domain of HcTnC (HcTnC1-89) under our buffering 
conditions in order to provide more information regarding the location of Cd2+ binding to the 
protein. To our surprise, ITC data yielded slightly unexpected results and data was best fit to a 
model suggesting the binding of four Cd2+ ions.  Data is presented below in addition to a 
discussion regarding the putative binding sites for each Cd2+ ion. 
 
4.1 Experimental 
Thermodynamic and CD spectroscopy studies were performed using the purified N-
domain of HcTnC (HcTnC1-89).  The recombinant pET3d plasmid containing the gene for 
HcTnC1-89 was generously donated by the Chalovich lab at the Brody School of Medicine. The 
plasmid was expressed in the BL21(DE3) pLysS host strain of Escherichia Coli. The procedure 
used for protein expression and purification of HcTnC1-89 is described In Appendix A. 
The Ca2+ and Cd2+ stock solutions for ITC and CD experimental analysis were prepared 
from atomic absorption standards purchased from Ricca chemicals. Metal stocks contained 5 
mM calcium or cadmium, 50 mM Bis-Tris, 100 mM KCl at pH = 7.0 and were stored at room 
temperature.  In the preparation of all buffers, 18 MΩ water was used and reagents were 
purchased from Sigma-Aldrich as more than 99% pure unless otherwise mentioned.   
 
 
 
4.2 Thermodynamics of Ca2+ binding to apo and Cd2+ bound HcTnC1-89 
Figures 19a and 19b represent Ca2+ binding to both apo and Cd2+ bound HcTnC1-89 
respectively.  Both thermograms in Figure 19 display a single endothermic binding event but 
with a several noticeable differences. First, the thermogram in Figure 19 displays a modest 
inflection at n=1 that is slightly sigmoidal in shape whereas the inflection in Figure 19b is less 
distinctive. Second, the titration of Ca2+ into apo protein reaches equilibrium after the addition of 
4 equivalents of Ca2+ whereas Ca2+  titrated into Cd2+ bound protein is shown to reach 
equilibrium after 40 equivalents of Ca2+ has been added.  This suggests that binding of Ca2+ to 
the apo protein is stronger than that of Cd2+ bound HcTnC1-89.  This is further supported by the 
conditional binding constants (K) listed in Table 4 where K for Ca2+ binding to the apo protein 
(3.8 × 104) is an order of magnitude larger than Ca2+ binding to Cd2+ bound HcTnC1-89 (2.3 × 
103).    
 The most important differences lie in the thermodynamic parameters noted in Table 4.  
The Gibbs free energy for Ca2+ binding to apo HcTnC1-89 is more favorable by 1.6 kcal/mol 
while the enthalpy of Ca2+ binding to apo protein is more favorable by 9.3 kcal/mol.  While both 
binding scenarios are entropically favored, the T∆S for Ca2+ binding to Cd2+ bound protein is 
more favorable suggesting that binding occurs with either more conformational flexibility or 
release of solvent into the bulk solution.   
These differences suggest that the binding interaction between Ca2+ and HcTnC1-89 is 
weakened in the presence of cadmium ion.  Either both calcium and cadmium ions are competing 
for the same binding site in the protein and Ca2+ is displacing Cd2+ thereby resulting in different 
thermodynamic parameters, or the cadmium ion could be interacting with the protein at an 
alternate site which could alter Ca2+ binding to the protein in loop II. As was discussed in 
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Chapter 3, Ca2+ and Cd2+ binding studies to full length HcTnC support the second scenario 
where Ca2+ binds to loop II and Cd2+ appears to bind to perhaps loop I in the N-domain. 
Therefore the presence of Cd2+ to loop I may alter the structure and binding of Ca2+ to loop II 
thereby resulting in a less favorable enthalpy and Gibbs free energy.  
 
 
 
Figure 19. Representative ITC data of (a) 0.5 mM Ca2+ titrated into 0.027 mM HcTnC1-89 
and (b) 2.0 mM Ca2+ titrated into 0.022 mM HcTnC1-89 containing 0.25 mM Cd2+. All 
samples are in 50 mM Bis-Tris (pH 7.0) and 100 mM KCl at 25 ˚C. Thermodynamic data 
are listed in Table 4. 
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Table 4.  Best fit thermodynamic parameters and corrected values for Ca2+ binding to 
apo and Cd2+ bound HcTnC1-89.  Thermodynamic values (∆G, ∆H and ∆S) are reported in 
kcal/mol.   
 
a.  Corrected Kb values are adjusted for buffer (Bis-Tris) at pH=7.0 and ionic strength 
of 0.1 M. 
 
 
4.3 Thermodynamics of Cd2+ binding to apo HcTnC1-89 
Cd2+ binding to apo HcTnC1-89 displays 3 distinct thermodynamic events (Figure 20a) in 
contrast to a single event seen for Ca2+ binding to apo protein. The first exothermic event occurs 
at a molar ratio of n=1 which is immediately followed by a second more exothermic event at 
n=2.  Both events have steep slopes associated with them indicating strong binding.  The third 
event is slightly less exothermic and shows slight sigmoidal behavior and a weak inflection at n= 
4 thus indicating weaker binding. Data were best fit to a “sequential set of sites model” with the 
number of sites set to 4.  Because it is difficult to distinguish binding of the third and fourth Cd2+ 
ion, parameters (K and H) were set equal to one another. The conditional binding constants in 
addition to remaining thermodynamic parameters are listed in Table 5.  
Each binding event is spontaneous as represented by the negative Gibbs free energy 
values of -10.0 (± 0.1) kcal/mol, -9.1 (± 0.1) kcal/mol and -6.1 (± 0.1) kcal/mol for Cd2+ ions 1, 
2, and 3=4 respectively. The enthalpies are all exothermic and favorable as represented by the 
 Apo HcTnC1-89 Correcteda Cd
2+ bound  
HcTnC1-89 
Correcteda 
n 0.98 (± 0.3)  fixed  
K  3.8 (± 0.3) ×104 2.9 (± 0.2) ×105 2.3 (± 0.6)×103  1.7 (± 0.5) ×104 
∆G  -6.2 (± 0.1)  -4.6 (± 0.2)  
∆H  5.5 (± 0.5)   14.8 (± 0.1)  
T∆S 11.7 (± 0.5)  19.4 (± 0.2)  
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respective ΔH values -7.3 (± 0.3) kcal/mol, -8.2 (± 0.6) kcal/mol, -9.0 (± 0.9) kcal/mol.  A 
positive and favorable entropy is associated with the first two binding events followed by a 
negative an unfavorable entropy for the third binding event. The entropy values are reported as 
2.7 (± 0.3) kcal/mol, 0.9 (± 0.6) kcal/mol, -2.9 (± 0.9) kcal/mol in Table 5 for each respective 
binding event.  
The two high affinity cadmium ions clearly bind more tightly than Ca2+ under the 
conditions studied.  When correcting for buffers (Table 4 and 5), the tightest bound cadmium ion 
has a Ka that is 3 orders of magnitude greater than Ca2+. Although Ca2+ may be able to compete 
with the third or fourth Cd2+ ion, it is clearly not capable of displacing the first two cadmium 
ions.   
 
4.4 The thermodynamics of Cd2+ binding to Ca2+ bound HcTnC1-89 
 Cd2+ ion binding to Ca2+saturated protein (Figure 20b) displays only two exothermic 
events as opposed to three observed in the apo scenario. The first thermodynamic event occurs at 
an n=2 while the second occurs at n=4. The first two sites are now indistinguishable and the data 
were fit to a “sequential set of binding sites” with sites 1=2 and 3= 4 respectively. All 
thermodynamic parameters can be found in Table 5. The conditional binding constant for both 
sites 1 and 2 was found to be 7 (± 1) ×106, which is within error to the second binding constant 
reported for Cd2+ binding to apo protein. This suggests that calcium present in the protein has 
weakened the binding of the first Cd2+ by an order of magnitude. The enthalpy of the first two 
cadmium ions binding to the protein is -9.0 (± 0.2) kcal/mol, which is 0.8 kcal/mol more 
favorable than the second Cd2+ binding to the apo protein. This suggests that calcium present in 
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the protein has also weakened binding to EF hand loop I and both Cd2+ ions are now binding 
with an average enthalpy of -9.0 kcal/mol. 
 While there are clear changes in the binding of the first two cadmium ions to the protein, 
the thermodynamic parameters for the third and fourth metal ions have not changed and all 
parameters reported are within error (Table 5).  This suggests that Ca2+ present in the truncated 
protein does not alter Cd2+ binding to these sites. 
 
 
Figure 20. Representative ITC data of (a) 0.5 mM Cd2+ titrated into 0.017 mM apo 
HcTnC1-89 and (b) 0.5 mM Cd2+ titrated into 0.016 mM HcTnC1-89 containing 0.125 
mM Ca2+.  All samples are in 50 mM Bis-Tris (pH 7.0) and 100 mM KCl at 25 ˚C.  
Thermodynamic data are listed in Table 5. 
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Table 5.  Best fit thermodynamic parameters for Cd2+ binding to apo and Ca2+ bound 
HcTnC1-89.  Thermodynamic values (∆G, ∆H and ∆S) are reported in kcal/mol.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. Corrected Kb values are adjusted for buffer (Bis-Tris) at pH=7.0 and ionic strength of 
100 mM. 
b. Sites 1 and 2 cannot be distinguished and either represent a β value or metals binding 
with the same affinity. 
 
 
 Apo HcTnC1-89 Correcteda Ca
2+ bound  
HcTnC1-89 
Correcteda 
K1   2.1 (± 0.3)×107 2.2 (± 0.3)×108 -- -- 
∆G1  -10.0 (± 0.1) -- -- -- 
∆H1 -7.3 (± 0.3) -- -- -- 
T∆S1 2.7 (± 0.3) -- -- -- 
K2 (β2) 5 (± 1)×106 5 (± 1)×107 7 (± 1)×106 b 8 (± 1)×107 
∆G2  -9.1 (± 0.2) -- -9.4 (± 0.1) -- 
∆H2 -8.2 (± 0.2) -- -9.0 (± 0.2) -- 
T∆S2 0.9  (± 0.3) -- 0.4 (± 0.2) -- 
K3,4 (β3.4) 3 (± 1)×104 3 (± 1)×105 2.7 (± 0.4)×104 2.9 (± 0.4)×105 
∆G3,4 -6.1 (± 0.1) -- -6.0 (± 0.1) -- 
∆H3,4 -9.5 (± 0.5) -- -9.4  (± 0.3) -- 
T∆S3,4 -3.4 (± 0.5) -- -3.4 (± 0.3) -- 
80 
 
 Figure 21. Circular dichroism data of ( ) 0.02 mM apo HcTnC1-89, ( ) 2 mM 
Ca2+ plus 0.02 HcTnC1-89, ( ) 2 mM Cd2+ plus 0.02 mM HcTnC1-89, and ( ) 2 
mM Ca2+ and 2 mM Cd2+ plus 0.02 mM HcTnC1-89.  All samples are in 10 mM Bis-Tris 
(pH 7.0) and 10 mM KCl.  Data were collected at 25 ˚C.   
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4.4 Circular dichroism of Ca2+, Cd2+, and Ca2+/Cd2+ bound to HcTnC1-89 
Figure 21 displays representative CD spectra of apo HcTnC1-89, Ca2+ bound HcTnC1-89, 
Cd2+ bound HcTnC1-89, and Ca2+/Cd2+ bound HcTnC1-89. There is a notable increase in ellipticity 
observed between 210 and 220 nm upon addition of Ca2+ to apo-HcTnC.  These changes are very 
small and therefor suggest minute structural difference between apo and metal bound species.  
This is further supported by the very small differences in the NMR structures of apo and Ca2+ 
bound HcTnC1-89 [85,100,137]. There is a slight difference in CD signal between the Ca2+ and 
Cd2+ bound HcTnC1-89 protein complexes.  Even more interesting, the spectra for the mixed metal 
species is superimposable with the Cd2+ spectra suggesting that Ca2+ has little impact on 
structure when Cd2+ is present.    
 
4.5 Conclusions 
  The recent crystal structure from Zhang and coworkers [32] revealed seven Cd2+ ions 
binding to the protein.  Our isothermal titration calorimetry data reveal that ~4 Cd2+ ions bind to 
the protein and that the other sites are too weak to be observed under our conditions.  Our data 
also reveal that Cd2+ binds three orders of magnitude stronger than Ca2+. Although ITC data do 
not indicate where these Cd2+ ions are bound, displacement studies reveal that the first Cd2+ 
binding to the protein is altered when Ca2+ ion is present. In addition, CD data indicate that Cd2+ 
ion changes the structure of HcTnC1-89 albeit slightly, and that this structure predominates in the 
presence of Ca2+ ion. Previous studies from Chapter 3 suggest that a weaker Cd2+ ion binds to 
loop I in the context of the full length protein.  We therefore conclude that the weaker Cd2+ ion 
also binds to loop I and that binding does not appear to be affected by the presence of Ca2+ in 
loop II.  We also believe that the 4th Cd2+ ion is perhaps is binding near loop I as observed in the 
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crystal structure due to the similarity of binding parameters but more studies need to be run in 
order to verify. 
What was most interesting was the presence of two high affinity sites.  The two high 
affinity sites in the full length protein were attributed to binding to the C-domain.  This was also 
supported by precious NMR studies investigating Cd2+ binding to bovine cardiac troponin C.  
Furthermore, two additional high affinity sites were also not observed in the full length protein 
studies. The presence of Ca2+ binding to the HcTnC1-89 appears to affect the mode of binding of 
the first high affinity Cd2+ ion. We propose that the two high affinity Cd2+ ions bind to the 
sulfur in Cys84 in a binuclear fashion as indicated in the crystal structure (Figure 9, Chapter 1).  
The absence of this thermodynamic signature in the full length protein may be due to the fact 
that Cys84 is very close to the linker region of the full length protein. Therefore, this cysteine 
residue may not be accessible to Cd2+ binding and is not observed in our full length binding 
studies.  More studies are required to characterize these possible sites in HcTnC1-89 and future 
studies may include mutant studies in combination with spectroscopic techniques such as 
Raman and 113Cd NMR. 
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 Chapter 5: Discussion and Future Directions 
 
5.1. Further thermodynamic support for Cd2+ binding to EF I in cTnC 
Although the crystal structure of N-cTnC was recently defined showing Cd2+ binding to 
the N terminal domain of cTnC there is no quantitative data that suggests Cd2+ is interacting at 
the EF I and EF II sites. Our studies provide the thermodynamic and structural analysis of  Cd2+ 
interacting with full length and truncated HcTnC while Figure 9 in Chapter 1 demonstrates the 
possible sites in which Cd2+ binds to the N terminal site, as previously defined through the 
crystallized structure of Cd2+ bound cTnC. Analysis of our results, while using the crystalized 
representation of Cd2+ binding sites as a guide, we can gain a deeper insight as to where Cd2+ is 
binding to the protein.   
In order to get a better idea of where Cd2+ is bound to the N domain of cTnC we first 
compared the thermodynamic data between the Ca2+ binding events from the full length and 
truncated studies in which only the Ca2+ binding site in the N terminal domain of CTnC was 
thought to be available. Based on our data we hypothesized, that Cd2+, when titrated into apo 
cTnC, binds to the C terminal EF hand sites and a site other than EF II in the N domain of 
cTnC. Therefore, the first set of data included in Table 5 represents Ca2+ binding to Cd2+ bound 
HcTnC. In addition, the second row of values represents the third Ca2+ binding event to apo 
HcTnC while the last row demonstrates the thermodynamics associated with Ca2+ binding to 
truncated apo HcTnC1-89 . The thermodynamics and binding curves associated the data shown in 
second and third row of table 5 have been previously identified as Ca2+ binding to EF II loop in 
the N domain [132]. Based on similar ΔG for the three scenarios, it appears that loop II in N-
domain is available for Ca2+ binding regardless of presence of Cd2+. These similar values also 
 
 
indicate that Ca2+ is not competing with Cd2+ for loop II, nor does Ca2+ appear to be competing 
for Cd2+ in the C-domain. Therefore, These data suggest that Cd2+ is binding to the protein at a 
site other than EF I,  and interaction between Cd2+ and the protein does not interfere or compete 
with Ca2+ binding to the N domain of cTnC.  
 
Table 6: Summary of Ca2+ Binding Data 
 
 
 
 
 
 
To supplement our conclusions, we also compared the thermodynamic data between the 
Cd2+ binding events from the full length and truncated studies in which the EF I site, or vestigial 
site, in the N terminal domain of cTnC was thought to be available.   
The almost identical ΔG values as demonstrated in Table 7, suggests that the Cd2+ is binding to 
the same site in both full length and HcTnC1-89, and appears to do so with the same ΔG 
regardless of the presence of Ca2+. Also, the thermodynamics of Cd2+ binding to HcTnC1-89 
remain unchanged with or w/o Ca2+present. Although previous Ca2+ data suggest that Cd2+ binds 
to loop II ,our data strongly demonstrates that Cd2+ is binding to EF I in the presence or absence 
of Ca2+.. 
 
 
Ca
2+
 Binding to… ΔG  kcal/mol 
ΔH  
kcal/mol 
TΔS 
kcal/mol 
Apo HcTnC (n=3) -6.4 1.3 7.7 
Cd
2+
 bound HcTnC  -5.6  5 10.6 
Apo HcTnC
1-89
 -6.2 5.5 11.7 
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Table 7: Summary of Cd2+ Binding Data 
 
 
 
 
 
 
 
 
To conclude, our results coupled to previous studies in the literature suggest that the 
putative binding sites for Cd2+ in cTnC, are the two C-domain sites and possibly the EF I site of 
cTnC in the full length protein. Additional sites in the isolated N-domain include a Cd2+ binding 
site near loop I or loop II and a binuclear site with bridging Cys84 residue located near the C-
terminus (Figure 9a-c, Chapter 1).  However, further studies are needed to verify these 
interactions.  
 
5.2. Possible Effects of Cd2+ Binding to EF I on CVD 
A recent study involving mutations of cTnC and the effects induced on Ca2+ infinity and 
the interaction occurring with cTnI [141]. In addition, further information on cardiac function 
was provided as a result of these effects. The preliminary results from the study demonstrated 
that ATPase activity increased due to prolonged contraction time as a result of a disruption in 
between the interaction of cTnI and cTnC [141]. These results thereby indicate that the 
interaction between cTnI and cTnC is critical for the heart muscle to efficiently transition from 
Cd
2+
 Binding to… ΔG  kcal/mol 
ΔH  
kcal/mol 
TΔS 
kcal/mol 
apo HcTnC (n=3)=3) -6.2  -1.3 4.9 
Ca
2+
 bound HcTnC (n=3) -6 -3.1 -2.9 
apo HcTnC
1-89
 -6.1 -9.5 -3.4 
Ca
2+
 bound HcTnC
1-89
 -6 -9.4 -3.4 
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contraction to relaxation phase. In addition, cTnI is regulated through PKA phosphorylation 
which phosphorylates the N extension of cTnI while bound to the N terminal cTnC. When this 
interaction was disabled there was a delay in phosphorylation of cTnI [141]. As a result ATPase 
activity increased, thereby indicating that the cardiac muscle protein units could have spent more 
time in the contracted state. Since our data indicates that  Cd2+ is interfering with defunct loop I, 
and the amino acids speculated to bind Cd2+ at this site are also binding ligands for cTnI, 
additional ATPase studies involving Cd2+ cTnC and cTnI may produce similar results as the 
cTnC/ cTnI mutation study. If so then we could suspect that Cd2+ interacting with this pathway 
could potentially cause an increase in cardiac ATPase activity, thereby concluding that the 
interaction of Cd2+ at the EF I site in the N domain of cTnC is possible pathway metal toxicity 
leading to CVD disease.  
Furthermore, other species have shown mutations in the EF I site that has also lead to 
changes in heart function. For example, ectothermic species have shown mutations ASn2, Ile28, 
Gln29, and Sp30 have functional importance in Ca2+ sensing at lower temperatures, such as 
having providing the TnC with a higher Ca2+ affinity [93]. How these mutations increase the 
affinity for Ca2+ is unknown. However, there is speculation that mutations in the N domain of 
cTnC may interfere with the interaction between cTnC and cTnI, which could have an effect on 
Ca2+ binding, and further effect the kinetics involved in cardiac muscle function as the heart 
transitions from the contracted to the relaxed state and vice versa. Although more data is needed 
to investigate evolutionary changes in cTnC and the effects of cTnI, the data available alludes to 
the conclusion that Cd2+ interaction at the N domain of cTnC, specifically in the EF I site, could 
impart serious implications on cardiac function.   
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5.3 Future Directions 
In order to continue with our studies of Cd2+ binding to HcTnC and the implications on 
the function of the protein as a result of metal binding, we would need to investigate more 
specifically where Cd2+ binding is preferred in the N-domain of cTnC. Possible experiments to 
probe Cd2+ binding to loop I include 113Cd NMR studies ,which display strong Cd2+ thiolate 
resonances at ~600 ppm, and Raman, which display Cd2+-thiolate bond stretching frequencies.  
In addition, mutant studies involving both the C domain and N domain would further aid in 
pinpointing Cd2+ binding to the protein and also provide information on the interaction between 
the EF hand loops and N and C domains. Once Cd2+ ion binding regions have been identified, 
one can begin to probe the effect Cd2+ may have on cardiac muscle function and HcTnC’s 
interactions with other troponin proteins. Cd2+ may be used to explore the novel cTnC and cTnI 
binding interactions.  
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Appendix A. Purification of HcTnC1-89 and Full length HcTnC 
 
PET3d plasmid vectors containing genes coding for HcTnC and HcTnC1-89 were 
generously donated by the Chalovich Lab at the Brody School of Medicine and were isolated and 
purified according to the protocol designed for the QlAprep spin Miniprep Kit. These plasmids 
were further transformed into cell lines XL1 Blue and BL21(DE3)pLysS respectively and stored 
at -80 °C until further use.    
Full length HcTnC and HcTnC (1-89) were overexpressed in their appropriate cell lines 
and purified using separate methods. The procedure used for protein expression and purification 
of full length HcTnC is described first, followed by the methods used to grow and isolate 
HcTnC1-89. 
  
A.1 Expression and Purification of Full Length HcTnC 
Cell stock’s containing the transformed XL1 Blue bacterial cells were removed from the -
80 °C freezer and streaked on to an LB agar plate containing 100 μg/mL of ampicillin. This 
medium was incubated at 37 °C overnight. The following day a single colony was removed and 
transferred into a 400 mL solution of LB broth containing 100 μg/mL of ampicillin. To achieve 
over-expressed protein levels, this 400 mL starter culture was allowed to grown shake overnight 
at 37 °C and 225 RPM. The next day 100 mL’s of this culture were transferred into four separate 
Fernbach flasks each containing a 900 mL solution of LB broth and 100 μg/mL of ampicillin. 
The four 1L cultures were allowed to shake at 37 °C and 225 RPM until the optical density of the 
solution measured at 600 nm reached an absorbance of 1.5. Once achieved, the cultured solutions 
 
 
were centrifuged for 15 minutes at 4°C at 4000 RPM. The resulting supernatant was discarded 
and the remaining pellet was prepared for purification. 
Following centrifugation of the culture, the resulting pellet was resuspended in a buffer 
solution containing 1 mM ethylenediaminetetraacetic acid (EDTA), 50 mM Tris/HCl (pH=8.0) at 
about 10-15 mL of resuspension buffer per liter of culture. A second solution containing 43 mg 
of protease cocktail in 0.2 mL of DMSO/0.8 mL of 18Ω water and 20 mg of deoxycholate was 
brought to 4 mL with 18Ω water was added to the resuspended pellet.  The solution was mixed 
thoroughly on ice until the pellet was completely resuspended. Approximately 50 mL of the 
resuspended solution was transferred to a clean sonication tube. This solution was then placed on 
ice and allowed to stir while sonicating at 2 min intervals set at a 30 seconds on 30 seconds off 
pulse rate (40% amplitude).   
The lysed samples were combined, mixed, and then centrifuged at 18,000 RPM for 15 
mins at 4°C. The supernatant was collected and the total volume was recorded. This value was 
then used to calculate the grams of salt needed to bring the solution to a final concentration of 5 
mM CaCl2 and 1 mM MgCl2. Ammonium sulfate was then added to produce 60% saturation. The 
sample was mixed and then centrifuged for 20 minutes at 18,000 RPM and 4°C. The resulting 
supernatant was collected and purified using a phenyl sepharose CL-4B column via hydrophobic 
chromatography. 
The supernatant was added to a 30 mL phenyl sepharose CL-4B column that had been  
pre-equilibrated using 500 mL of a buffer containing 1 M NaCl, 1 mM CaCl2 and 50 mM 
Tris/HCl at a pH=8.0. The sample was washed with 500 mL of the equilibration buffer. Then, a 
solution gradient was set up to wash the sample with 300-500 mL of wash buffer followed by 
300- 500 mL of elution buffer. Wash buffer contained 1 M NaCl, 0.2 mM CaCl2 and 50 mM 
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Tris/HCl at a pH=8.0 while elution buffer consisted of 5 mM EDTA and 20 mM Tris/HCl 
pH=8.0.  
A gravity flow system was used to elute samples from the column. These samples were 
collected in 5 mL increments using the Retriever Fraction Collector. The absorbance of each 
fraction was measured and recorded using UV-vis spectroscopy (Thermo Scientific NanoDrop 
2000C spectrophotometer) at 280 nm. Fractions producing a large absorbances, specifically 
those eluted in elution buffer, were tested for impurities via gel electrophoresis using a 12% 
polyacrylamide gel (Figure A1). 
 
 
Figure A1. A 12% polyacrylamide Gel showing fractions eluted with 5mM EDTA 
20mM Tris/HCl. Gel represents fractions contained pure HcTnC. The molecular 
marker (in kDa) used was an EZ-RunTM Pre-stained Rec Protein Ladder shown in 
lane 1. 
  
 
Fractions demonstrating little to no impurities were collected and either stored in -80 °C 
or used immediately in experimental analysis. Beer’s law was then used to calculate the Protein 
concentrations for these samples using an extinction coefficient (Є) of 4595 cm-1 M-1, a path 
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length of 1 cm and the absorbance value for that sample in a Beer’s Law calculation. This value 
was recorded and used in calculations involved in the experimental design. 
  
A.2 Expression and Purification of HcTnC1-89 
 Cell stock’s containing the transformed BL21(DE3)pLysS bacterial cells were removed 
from the -80 °C freezer and streaked on to an LB agar plate containing 100 µg/mL of ampicillin. 
This medium was incubated at 37 °C overnight. The following day a sterile batch of 400 mL of 
LB broth containing 100 μg/mL ampicillin was inoculated with a colony produced on the agar 
plate.  This starter culture was incubated overnight at 37 °C at 225 RPM.  
The following morning four Fernbach flasks, each containing a sterilized solution of 900 
mL of LB broth and 100 μg/mL of ampicillin, were prepared. To each Fernbach flask, 100 mL of 
the O/N culture was added. After an hour of growth at 37°C and 225 RPM, the optical density of 
the solution was measured at 600 nm. If the solution did not obtain an optical density between 
0.8-1.000 in the first measurement, incubation was continued while performing frequent 
measurements.  
When the optical density of the solution rose to the optimal range, protein expression was 
then induced by adding stock solutions solution of isopropyl β-D-thiogalactopyranoside to a final 
concentration of 5 mM. The cells were allowed to incubate at 37 °C and 225 RPM for 4 hours. 
Following this time, the solution was centrifuged at 4000 RPM in 15 minute intervals. The 
supernatant was discarded and the pellet was resuspended and purified. For a more successfully 
purification of HcTnC1-89, half of the resulting pellet was used while the other half was stored at  
-80 °C until further purified. 
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The cell pellet of the cultured solution was resuspended by adding a 5 mL lysozyme 
solution for every liter of culture. The lysozyme solution consisted of 1mg/ml of lysozyme in 
20% sucrose, 20 mM Tris-HCl at pH 7.5, 1 mM EDTA, and 0.2 mM phenylmethylsulfonyl 
fluoride. After incubating the resuspended solution at 4 °C for 20 minutes, 20 mL (per liter of 
cell culture) was added of the following solution: of 20 mM Tris-HCl at pH7.5, 1 mM EDTA, 
0.5 mM dithiothreitol and 0.2 mM phenylmethylsulfonyl fluoride. The solution was then stirred 
on ice at 4 °C for 10-15 minutes and then sonicated for 4 mins at a 25% duty cycle, and an 
output control of 2.5. The sample was then centrifuged at 18000 RPM for 15 minutes at 4 °C. 
The supernatant was collected fixed to a final concentration of 10mM CaCl2, 1 M NaCl 
and then slowly added onto on a 100 mL phenyl-Sepharose CL-4B column at room temperature 
via gravity flow. Runoff was collected in 5 mL samples. Prior to adding the sample to the 
column, the column had been equilibrated  with 500 mL wash  buffer I consisting of  50 mM 
Tris-HCl at pH 7.5, 10 mM CaCl2, 1 mM MgCl2, 1 mM DTT and 1 M NaCl.  
Once the sample was loaded onto the column 300 mL of wash buffer I was then used to 
wash the sample.  Wash buffer II consisting of 50 mM Tris-HCl at pH 7.5, 5 mM CaCl2, 1 M 
NaCl, and 1 mM DTT and wash buffer 3 consisting of 50 mM Tris-HCl at pH 7.5, 0.1 mM 
CaCl2, 1 M NaCl, and 1 mM DTT were washed over the sample in a gradient fashion. An elution 
buffer of 50 mM Tris-HCl at pH 7.5, 1 mM EDTA, and 1 mM DTT was then used to elute the 
protein from the column. 5 mL fractions were collected during all washes and elution. The 
absorbances of each fraction were measured. The purity of fractions giving large absorbance 
values was tested using gel electrophoresis (Figure A2). The molecular weight of HcTnC is 
approximately 10 kD. 
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 Figure A2. A 15% polyacrylamide Gel showing fractions eluted with 50 mM 
Tris-HCl at pH 7.5, 1 mM EDTA, and 1 mM DTT. Gel represents fractions 
containing slightly pure HcTnC(1-89). The molecular marker used was a 
“Prestained Rec Protein Ladder” shown in lane 1. 
  
 
In order to ensure that all protein was Ca2+ free the protein was brought to 2 mM EDTA 
concentration. The protein was then dialyzed against the buffer to be used in ITC experiments. 
The buffers used was 50 mM Bis-Tris pH 7.0, 50 mM KCl. The dialysis was performed with 1 
liter of the dialysis buffer three times with four hours between each liter. All buffer solutions 
were adjusted to a pH=7.0.  
Calcium and cadmium stock solutions of 5 mM were prepared in each buffer. The metal 
and protein solutions to be used in ITC experiments were diluted with the corresponding dialysis 
buffer. Preparation of Ca2+ solutions in this manner served to ensure that protein and metal were 
in identical buffer. 
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